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Embryos from diabetic mice exhibit several forms of neural tube defects including non-closure 
of the caudal neural tube. In the present study, embryos collected at embryonic day 11.5 from 
diabetic pregnancies displayed open neural tube with architectural disruption of the surrounding 
tissues and impaired development of dorsal root ganglia (DRG). The percentage of proliferating 
cells was found to be increased in the dorsal and ventral domains of the spinal neural tube of 
embryos from diabetic mice, indicating a defect in the precise timing of cell-cycle exit. The 
development of various cell types including motoneurons, interneurons, oligodendrocytes and 
migrating neurons as well as radial glial cells in the open neural tube using specific molecular 
markers have also been analyzed. Immunofluorescence results revealed a significantly reduced 
number of Pax2+ interneurons and increased number of Isl-1+ motoneurons as well as Olig2+ 
oligodendrocytes in the caudal neural tube of embryos from diabetic mice as compared to 
controls. In addition, these embryos exhibited a decreased number of doublecortin-positive 
migrating neurons and Glast/Blbp positive radial glial cells with shortened processes in the 
neural tube. Expression levels of several developmental control genes involved in generation of 
different neuronal cell types (such as Shh, Ngn, Ngn2, Ascl1) were also found to be altered in the 
caudal neural tube of embryos from diabetic mice. Sensory neurons in the DRGs of embryos 
from diabetic mice were found to have a lower proliferation index as compared to controls. The 
development of the sympathetic chains in the PNS was also affected by maternal diabetes as 






Overall, the open neural tubes in embryos of diabetic mice are associated with defects in 
the timing of cell-cycle exit, cell migration and specification of different cell types including 
motoneurons and interneurons as well as glial cells along the dorsoventral axis of the developing 
spinal cord. As these neuronal cell types in the spinal cord provide a network that modulates the 
sensory and motor output in both peripheral and central nervous systems, defective development 
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1.1 Diabetes mellitus 
1.1.1 General background of diabetes mellitus 
Diabetes mellitus is characterized by chronic hyperglycaemia that results from a 
deficiency in or resistance to insulin, or both. According to the World Health 
Organization, diabetes is a rising global burden that affects approximately 171 million 
people worldwide in the year 2000. This number is projected to more than double over 
the next 25 years to reach a total of 366 million by 2030 due to urbanization, population 
explosion and an increase in obesity and sedentary lifestyle.  
 
Diabetes may be primary or secondary although secondary diabetes accounts for 
only approximately 1-2% of all new cases presented (Kumar and Clark, 1998). Primary 
diabetes can be categorized into two subgroups: type I insulin-dependent diabetes 
mellitus (IDDM) and type II non-insulin-dependent diabetes mellitus (NIDDM). IDDM 
is a HLA-linked autoimmune disease that results from a loss of β cells in the pancreas 
that produces insulin (Cudworth and Woodrow, 1976; Bottazzo et al., 1978). Formerly 
known as juvenile- or childhood-onset diabetes, IDDM has been shown to affect children 
and young adults likewise, thus abolishing the long held notion that IDDM is exclusively 
a childhood problem. In contrast, NIDDM is a metabolic disorder that is characterized by 
a resistance to insulin. Unlike patients with IDDM, those with NIDDM retain about 50% 
of their β-cell mass. This form of diabetes is more commonly prevalent in populations 
enjoying an affluent lifestyle. In addition to these two subgroups of diabetes mellitus, 
gestational diabetes mellitus (GDM) is a separate group of diabetes mellitus that develops 
 




during the course of pregnancy and usually remits following delivery (Kumar and Clark, 
1998).  
 
1.1.2 Complications associated with diabetes mellitus 
It was initially assumed that the introduction of insulin would provide a complete 
replacement therapy. However, time has proved that insulin-treated patients have a 
considerably reduced life expectancy with a host of complications related to vascular 
diseases. Vascular disease, which is subdivided into macrovascular and microvascular, is 
a major complication of diabetes mellitus. Macrovascular complication such as 
atherosclerosis can results in stroke, ischaemic heart disease and peripheral vascular 
disease. Various factors such as alterations in lipoproteins, platelets, soluble clotting 
factors, the balance of prostacyclin-thromboxane, blood pressure regulation and arterial 
smooth muscle cell metabolism and proliferation may all play a part in promoting the 
acceleration of atherosclerosis in patients with diabetes mellitus (Colwell et al., 1981; 
Steiner, 1981). Microvascular complications are of great concern to patients with diabetes 
mellitus as they can affect important sites such as the retina, renal glomerulus and the 
nerve sheath. Diabetic retinopathy is one of the leading causes of blindness in adults 20-
74 years of age in industrialized countries and is the result of microvascular retinal 
changes that manifest as microaneurysm and hemorrhage in the retina (Aiello et al., 
1981). The prevalence of diabetic retinopathy has been observed to increase with the 
duration of diabetes. Risk factors of retinopathy include poor management of glucose 
levels, arterial hypertension and coexistence of other late complications (Pinto-Figueiredo 
 




et al., 1992). Diabetic nephropathy is a common cause of chronic kidney failure and end-
stage kidney disease in patients with chronic diabetes. The risk of developing this 
progressive disease is directly linked to the management of glucose levels. Indeed, it was 
reported that management of blood glucose levels close to the normal range in patients 
with IDDM reduces damage to the kidneys by 35% to 56% (The Diabetes Control and 
Complications Trial Research Group, 1993). Diabetic neuropathy is another long-term 
complication of diabetes mellitus that results from microvascular injury to the somatic or 
autonomic nerves. It affects up to 50% of patients (Vinik et al., 2003; Boulton, 2007) and 
is a major cause of amputation and foot ulceration (Boulton et al., 2005). The most 
common type of diabetic neuropathy is the length-dependent diabetic polyneuropathy 
which affects the longest nerve fibers first (Said, 2007). This explains why signs and 
symptoms start in the feet first before progressing to more proximal areas of the lower 
limbs.         
 
1.1.3 Maternal diabetes and congenital malformations 
Maternal diabetes is associated with complications in infants such as macrosomia, growth 
retardation, acute respiratory distress and congenital malformations (Hollingsworth and 
Cousins, 1984; Kumar and Clark, 1998). Congenital malformations which may occur 
before the seventh week of gestation are the leading cause of perinatal deaths in infants 
born to diabetic mothers (Kuhl et al., 1998). Prevalence trends and data of maternal 
diabetes are scant and are largely based on population studies in the United Kingdom, 
New Zealand and North America which indicate a general rising trend in tandem with 
 




growing affluence (Feig and Palda, 2002; Wild et al., 2004; Macintosh et al., 2006). An 
increase in maternal diabetes is a worrying trend as it entails a climb in congenital 
abnormalities which include cardiovascular abnormalities such as cardiomegaly and 
transposition of great vessels, gastrointestinal abnormalities such as pyloric stenosis and 
anorectal atresia, urogenital abnormalities such as renal agenesis and renal cysts, 
musculoskeletal abnormalities such as cleft palate and craniosynostosis, and 
abnormalities involving the central nervous system (CNS) (Kousseff, 1999). With an 
incidence of 7.8% to 9.7% in diabetic mothers in comparison to approximately 2.1% in 
the non-diabetic population in Washington State and Atlanta, USA, this is certainly a 
cause for concern (Becerra et al., 1990; Janssen et al., 1996).  
 
1.1.4 Maternal diabetes-induced neural tube defects 
Infants of diabetic mothers face a risk of having an array of CNS deformities such as 
hydrocephalus, cardiac anomalies, anencephaly and spina bifida (Mills et al., 1979; 
Becerra et al., 1990). Such malformations in the neural tube i.e. neural tube defects 
(NTDs), have been reported to be higher in embryos of diabetic pregnancies than in non-
diabetic pregnancies (Malins, 1978). NTDs, including spina bifida and anencephaly, are a 
group of severe disabling or life-threatening congenital abnormalities that occur when 
neural folds fail to elevate and fuse at the midline. Anencephaly results when the cephalic 
end of the neural tube fails to close, thus resulting in the absence of the development of 
the brain, skull and scalp. Incomplete closure of the posterior neural tube results in spina 
bifida in common areas such as the lumbar and sacral regions of the spinal cord. The 
 




incidence of NTDs varies in the world depending on the geographic location and 
ethnicity. In Peurto Rico where most residents are Hispanic, the prevalence of NTDs is 
8.68 per 10,000 live births. This figure is higher than in the United States where every 
10,000 live births result in an occurrence of 5.59 births with NTDs (Centers for Disease 
Control and Prevention (CDC), 2008). Interestingly, another population-based study 
reported a twofold increased risk of NTD-affected pregnancies among Mexico-born 
women in the United States (Velie et al., 2006). The prevalence of NTDs in Western 
Australia is around 2 per 1000 births from 1966 to 1995 and since then, a fall of 29% that 
coincided with the promotion of folic acid supplement (Bower et al., 2004).  
 
In recent years, several studies attempted to unravel the molecular mechanisms by 
which maternal diabetes induces NTDs by using rodent models. It has been suggested 
that diabetes in vivo and high glucose in vitro alter the expression of several genes 
involved in neural tube development, subsequently contributing to NTDs (Fine et al., 
1999; Liao et al., 2004; Fu et al., 2006). Intracellular oxidative stress from free radicals 
such as reactive oxygen species (ROS) has also been implicated in diabetic complications 
which include congenital malformations (Hockett et al., 2004; Niedowicz and Daleke, 
2005). However, the exact mechanism that contributes to NTDs in maternal diabetes has 










1.2 Development of the neural tube 
1.2.1 Gastrulation: From cells to embryo 
Gastrulation is an early phase in the development of animal embryos, during which the 
germ layers are formed and the body plan of the mature organism is established.  During 
gastrulation, the three germ layers (endoderm, mesoderm and ectoderm) that are formed 
in the developing vertebrate embryos give rise to the primordia of all the tissues and 
organs. The endoderm, the innermost layer, gives rise to the lungs, liver and inner linings 
of the gut while the mesoderm the middle layer, gives rise to connective tissues, muscle 
and the vascular system. The outermost layer, the ectoderm, gives rise to the major 
tissues of the central and peripheral nervous systems and the skin.  
 
1.2.2 Mechanisms of neurulation 
The prechordal plate and notochord are responsible for initiating the process of 
neurulation by inducing the formation of the neural plate from overlying ectoderm cells. 
Neurulation is a key event of embryogenesis and is initiated with the folding of the neural 
plate at the midline that creates neural folds that form the neural groove. Subsequent 
elongation of the neural plate occurs by convergent extension whereby lateral cells are 
rearranged and intercalated into the midline (Schoenwolf and Alvarez, 1989; Keller et al., 
2000). Elevation and bending of the neural plate are necessary to form a tubular structure 
called the neural tube in which the caudal region of the neural tube gives rise to the spinal 
cord and the rostral region becomes the brain. Bending of the neural plate is based on the 
 




formation of three hinge points in the neural tissue: a median hinge point (MHP) where 
the neural plate is anchored to adjacent tissues, and paired lateral hinge points (LHP) 
where the neural plate is anchored to the prospective epidermis of the neural folds. Each 
hinge facilitates bending of the neural plate that results in convergence of the neural plate 





1.2.3 Closure of the neural tube 
The closure of the mouse neural tube at embryonic day (E) 8.5 has been described as a 
sequence of events that begins at the boundary between the cervical and hindbrain region 
and proceeding both rostrally and caudally (site 1). The closure of the brain results from 
de novo events at two initiation sites: at the forebrain-midbrain boundary (site 2) and at 
the rostral extremity of the forebrain (site 3) (Copp et al., 2003). Although sites of closure 
1 and 3 have been relatively uniform between mouse strains, it has been reported that the 
site of closure 2 is polymorphic and even absent in some mouse strains (Juriloff et al., 
Illustration 1. Mechanism of 
neural plate bending with the 
hinge point model. Blue 
represents dorsolateral hinge 
points and red represents median 
hinge point. Asterisks indicate 
furrowing associated with the 
hinge points. ee: epidermal 
ectoderm; n: notochord. (Colas 
and Schoenwolf, 2001) 
 




1991). The closure of the human neural tube was earlier over-simplified and described as 
a continuous event that initiates at the level of the future cervical region and proceeds 
both rostrally and caudally (O'Rahilly and Muller, 1994). However, with multiple 
initiation sites of neural tube closure being described in mice and other species, it soon 
became clear that the closure of the human neural tube involves more than just a single 
site of initiation. Indeed, a model with five closure sites has been proposed by Van Allen 
et al. based on the study of the type and frequency of human NTDs (Van Allen et al., 
1993). In their model, the initiation sites of neural tube closure in humans are similar to 
that of the mice as described by Copp and coworkers (Copp et al., 2003) with the 
exception of two additional sites: site 4 which covers the rhombencephalon and 
completes the closure of the cranial neural tube; and site 5 that initiates from the caudal 
end of the neural groove and spreads cranially (Illustration 2). Subsequent studies on the 
histological examinations of human embryos lead to models that described three sites 
(Nakatsu et al., 2000) and two sites (O'Rahilly and Muller, 2002) of apposition in the 
closure of the human neural tube.  
 
Illustration 2. Mechanisms of neural 
tube closure in human (red lines) and 
mouse (black lines). A closure event at 
closure 2 (represented by single asterisk) 
occurs in most mouse strains with more 
caudal and rostral locations of closure in 
some other strains (dashed lines with 








1.2.4 Molecular factors involved in neural tube development 
1.2.4.1 Dorso-ventral patterning of the neural tube 
After neural induction and the formation of the neural tube, patterning along the rostro-
caudal (RC) and dorso-ventral (DV) axes begins and cells start to acquire regional 
identities with signals from morphogens. Morphogens are secreted signaling molecules 
that act at a distance in a concentration-dependent manner to control cell fate and 
patterning of the neural tube (Monuki and Walsh, 2001; Cayuso and Marti, 2005). The 
DV patterning of the neural tube is dictated by the antagonistic action of sonic hedgehog 
(Shh) emanating from the ventral regions and by bone morphogenetic proteins (BMPs) 
from the dorsal regions of the neural tube in a graded fashion (Liem, Jr. et al., 1997). 
Wingless-related MMTV integration site (Wnt) protein, another extracellular signaling 
molecule present in the roof plate, has been implicated as a mitogen for inducing 
proliferation in the neural tube rather than being directly involved in DV patterning 
(Megason and McMahon, 2002).   
 
1.2.4.1.1 Sonic hedgehog (Shh)  
Shh, a secreted protein synthesized by the notochord and floor plate, is necessary as a 
ventralizing signal for the patterning of the ventral neural tube (Roelink et al., 1994; 
Marti et al., 1995b; Chiang et al., 1996). The establishment of a ventral-to-dorsal 
decreasing concentration of Shh activity controls neuronal fate by either inducing or 
repressing the expression of several progenitor cell homeodomain transcription factors 
and is responsible for the generation of five ventral neuronal progenitor subtypes (Ericson 
 




et al., 1997a; Ericson et al., 1997b; Briscoe and Ericson, 2001). The initiation of Shh 
signaling requires the binding of Shh to its receptor, Patched (Ptc), which is a 12-
transmembrane protein (Marigo et al., 1996; Stone et al., 1996). The binding of Shh to 
Ptc releases the inhibition of a seven-pass transmembrane protein Smoothened (Smo), 
which is responsible for transmitting the intracellular signal (Alcedo et al., 1996; van den 
and Ingham, 1996). Further downstream signal transduction by Smo results in the 
regulation of the activity of the Gli family of zinc finger transcription factors (Sasaki et 
al., 1999). In the developing neural tube, these Gli proteins appear to regulate Shh–
responsive homeobox genes that specify ventral neuronal cell fates (Persson et al., 2002).  
 
In addition to its instructive role, Shh has been demonstrated to play a mitogenic 
role by promoting the proliferation of neural progenitor cells in the neural tube (Liem, Jr. 
et al., 1997; Cayuso et al., 2006). It was reported that the removal of the notochord causes 
a decrease in the size of the neural tube (Charrier et al., 2001) while ectopic activation of 
Shh signaling pathway (Epstein et al., 1996; Hynes et al., 2000) and ectopic expression of 
Shh (Rowitch et al., 1999) results in the hyper-proliferation of progenitors. Shh has also 
been shown to regulate the proliferation of oligodendrocyte precursors (Davies and 
Miller, 2001) and neural crest cells (Ahlgren and Bronner-Fraser, 1999). The importance 
of Shh signal is further demonstrated in Shh knockout mice where midline structures are 
not maintained and the neural tube is dorsalized (Chiang et al., 1996).  
   
 
 




1.2.4.1.2 Bone morphogenetic proteins (BMPs) 
The BMPs represent a subclass of the transforming growth factor-β (TGF-β) superfamily 
with more than 20 members that signal transduce through serine-threonine kinase 
receptor subunits (Kingsley, 1994; Hogan, 1996).  BMPs are involved in early 
neurulation and they are expressed in the overlying ectoderm and roof plate for 
subsequent neuronal patterning of the dorsal half of the neural tube (Liem, Jr. et al., 1995; 
Liem, Jr. et al., 1997; Lee and Jessell, 1999). Like their mutually repressive counterpart 
Shh, BMPs act as morphogens and mediate long- and short-range signaling during 
development (Tanabe and Jessell, 1996; Lecuit et al., 1996).  
  
The role of BMPs in the patterning of the dorsal aspect of the neural tube has been 
widely studied. In the developing chick embryo, BMP4 and BMP7 induce dorsal cell 
types in neural plate explants (Hogan, 1996). As the neural plate elevates and folds into 
the developing neural tube, high expression levels of BMP4 are found in the dorsal neural 
folds and midline. In contrast, BMP2 is expressed in the anterior neural folds of the 
developing mouse embryo (Winnier et al., 1995). The murine neural tube expresses 
different BMPs family members upon closure and maturation. BMP4 is expressed in the 
anterior dorsal midline while BMP6 is expressed along the whole axis (Jones et al., 1991). 
Mutant studies by Nguyen et al. confirmed the importance of BMP signaling in the 
establishment of the prospective neural crest and dorsal sensory neurons in the zebrafish 
neural tube (Nguyen et al., 2000).   Besides patterning the dorsal aspect of the neural tube, 
BMP4 is also implicated in apoptosis around the nervous system. For example, in 
 




rhombomere cultures where exogenous BMP4 has been added, apoptosis is induced 
(Graham et al., 1993).  
   
1.2.4.1.3 Wingless-related MMTV integration site (Wnt) 
Wnts proteins form a family of highly conserved cysteine-rich secreted signaling 
molecules with at least 16 members in the mouse related to Drosophila Wingless. Four of 
these members, Wnt1, 3, 3a and 4, are expressed in overlapping regions at the dorsal 
midline from the forebrain to the spinal cord (Parr et al., 1993) and they have been 
implicated in proliferation and survival of neural progenitors in the dorsal regions of the 
caudal neural tube (Dickinson et al., 1994; Megason and McMahon, 2002). Multiple in 
vivo studies have demonstrated the important role of Wnts in the regulation of growth in 
the caudal neural tube. It is interesting to note that Wnt1 null mutant embryos displayed 
no apparent phenotype although Wnt1 is predominantly expressed in the dorsal regions of 
the CNS. It has been suggested that Wnt3a, another Wnt member that is expressed in the 
same region, may be functionally redundant with Wnt1 (McMahon et al., 1992). 
Subsequent double mutants and ectopic expression studies revealed more functional 
information on these members of the Wnt family that are expressed in the dorsal midline 
of the neural tube. Wnt1/Wnt3a double mutant embryos displayed a loss or diminished 
development of  neural crest derivatives and cell types characteristic of the dorsal neural 
tube (Ikeya et al., 1997; Muroyama et al., 2002) while ectopic expression of Wnt1 in 
transgenic mice yielded an overgrowth of the neural tube without altering cell identities 
along the DV axis (Dickinson et al., 1994).  
 




 In recent years, it has been suggested that a certain degree of cross-talk exists 
between the Wnt and BMP signaling pathways. Wnts have been shown to 
transcriptionally induce BMPs and vice versa in a reciprocal relationship during the 
development of the neural tube (Chesnutt et al., 2004; Ille et al., 2007). These data, 
coupled with the finding that Wnt-β-catenin promotes G1 to S phase of the cell cycle 
progression (Megason and McMahon, 2002) puts forth a view that growth in the 
developing neural tube is regulated by a balance between Wnt and BMP signaling in 
which Wnt signaling is ascribed a role in promoting cell cycle progression while BMP 
favors cell differentiation.          
 
1.2.4.2 Specification of neuronal fates in the neural tube 
Our understanding of the origin of neuronal cell types in the neural tube initially came 
from experiments conducted in the rat and chick (Altman and Bayer, 1984; Oudega et al., 
1993; Leber and Sanes, 1995). Over the years, advances in genetics made the creation of 
mouse mutants possible and these have served to further our knowledge in the 
specification of cell types in the neural tube. In the developing mouse embryo, 
neurulation starts at E8.5 and neural progenitor cells that are produced in the ventricular 
zone of the neural tube express molecular markers that are characteristic of their DV 
position by E9.5 (Lee and Jessell, 1999; Jessell, 2000; Briscoe and Ericson, 2001). Then, 
through various combinatorial molecular factors, some of these progenitor cells leave the 
cell cycle and migrate laterally from the ventricular zone to the mantle layer where they 
differentiate into mature neurons expressing various neuronal markers.  
 




Neuronal circuits that are involved in the control and coordination of motor output 
reside predominantly in the ventral half of the neural tube. Past and recent experimental 
studies have culminated in a model in which graded Shh signaling in the ventral neural 
tube controls the expression of a group of homeodomain (HD) proteins, which in turn, 
establishes five domains of progenitor cells (Illustration 3) (Wilson and Maden, 2005). 
These HD proteins that identify the five domains of progenitors later go on to specify 
neuronal subtypes that express distinctive gene expression markers during differentiation. 
The inactivation and ectopic expression of individual HD proteins in the mice and chicks 
respectively, demonstrate the position at which individual neurons are generated (Ericson 
et al., 1997b; Mansouri and Gruss, 1998; Briscoe et al., 1999; Briscoe et al., 2000; Sander 
et al., 2000). The five ventral progenitor (p) domains, vp0-vp3 and progenitor 
motoneurons (pMN) generate ventral V0-V3 neurons and somatic motoneurons (sMN) 
respectively. The combinatorial actions of three HD proteins, Dbx, Pax6 and Irx3 
mediate the position of the three most ventral neuronal subtypes while Olig2 and Nkx2.2 
control the position of motoneurons and V3 neurons respectively. Motoneurons represent 
a minor fraction of the neurons that populate the ventral spinal cord and Isl1 is initially 
required for their generation (Pfaff et al., 1996) and it is the interneurons that projects and 
wire the local circuit that predominate (Brown, 1981), and are crucial in integrating 
motor output. Earlier studies have demonstrated that Pax2, a paired-box transcription 
factor, is expressed in multiple interneuron cell types including a population of 
interneurons that coexpress Engrailed1 (En1) and require Pax6 for development (Burrill 
et al., 1997).   
 




Neurons located in the dorsal half of the spinal cord play a critical role in 
mediating and integrating sensory input from the periphery to central targets. It has been 
clearly demonstrated that there are 6 groups of early-born post-mitotic dorsal neurons, 
dl1-dl6, in the dorsal half of the spinal cord that are defined mainly by the expression of 
HD transcription factors (Illustration 3) (Gowan et al., 2001; Gross et al., 2002; Muller et 
al., 2002). These neurons are derived from progenitors that are indicated by the 
expression of basic helix-loop-helix (bHLH) proteins Atoh1, Neurogenin1 (Ngn1), 
Neurogenin2 (Ngn2) and Ascl1 (Lee et al., 1998b; Lee et al., 2000; Helms and Johnson, 
2003). dl1-dl3 neurons are dependent on roof plate signals while dl4-dl6 neurons are not 
(Lee et al., 2000; Muller et al., 2002). In addition to these neuron populations, there are 2 
later-born postmitotic populations that arise from E11.5 called dILA and dILB. dILA/B 
neurons migrate to the superficial laminae of the dorsal horn and become association 
neurons that integrate sensory input (Brown, 1981). Majority of post-mitotic dorsal 
neurons except dl4 and dl6 neurons (which express Pax2) express Brn3a in the mantle 
zone of the neural tube.    
 





Illustration 3. The dorsoventral patterning of the developing neural tube with its gene 
and protein markers that are used to identify the progenitor and neuronal cell types. RP: 
roof plate; FP: floor plate; vz: ventricular zone. (Modified from Wilson and Maden, 
2005). 
 
1.2.4.2.1 Basic helix-loop-helix proteins 
First described in 1989, the basic helix-loop-helix (bHLH) proteins are a class of 
transcription factors with a structural motif that bind to DNA and dimerize (Murre et al., 
1989a; Murre et al., 1989b). Proteins of this class play a critical role in differentiating 
neurons and determining neuronal lineages in the CNS and peripheral nervous system 
(PNS). Genes such as Atoh1, Neurogenins and Ascl1 are involved in the specification of 
 




neural precursor populations while others (such as NeuroD) are expressed mainly in 
differentiated neurons (Lee, 1997).  
    
1.2.4.2.1.1 Mammalian atonal homolog 1 
A homolog of the Drosophila proneural gene atonal, Mammalian atonal homolog 1 
(Atoh1) is a neural-specific mammalian bHLH transcription factor that is transiently 
expressed in the developing CNS. Atoh1 mRNA is prominently expressed in dividing 
neural progenitors of the dorsal region adjacent to the roof plate of the neural tube 
(Akazawa et al., 1995; Ben-Arie et al., 1996).  
 
Early transgenic studies have suggested that Atoh1-expressing neuronal 
precursors in the dorsal neural tube give rise to dorsal commissural neurons (Helms and 
Johnson, 1998). Subsequently, other groups have demonstrated with mutational studies in 
mice that progenitor cells expressing Atoh1 give rise specifically to dl1 cells (Helms and 
Johnson, 1998; Bermingham et al., 2001; Gowan et al., 2001) that is positive for LIM-
class HD proteins LH2A, LH2B and POU-domain transcription factor Brn3a (Gowan et 
al., 2001). In addition to mutational analyses, Gowan and colleagues also studied the 
ectopic expression of Atoh1 in the neural tube and found that dl1 interneurons were 
induced at the expense of other regional interneurons (Gowan et al., 2001). These studies 








1.2.4.2.1.2 Neurogenin 1 and Neurogenin 2 
Neurogenin 1 (Ngn1) and neurogenin 2 (Ngn2) are mammalian orthologs of the 
Drosophila proneural bHLH gene atonal with expression in precursors of  placode- and 
neural crest-derived sensory neurons (Ma et al., 1996; Gradwohl et al., 1996; Ma et al., 
1997). Neurogenins were first reported in both mouse and Xenopus with expression 
preceding and overlapping that of NeuroD (Ma et al., 1996; Sommer et al., 1996).  Ngn1 
defines a population of progenitor cells that is immediately ventral to Atoh1-expressing 
domain that gives rise to dl2 neurons (Gowan et al., 2001) while Ngn2 partially overlaps 
with Ngn1 and Ascl1 (Helms et al., 2005).  
 
The expression of Ngn1 or Ngn2 in dissociated neural tube cell cultures has 
implicated a function for them in inducing sensory neurons more than promoting 
neuronal differentiation (Parras et al., 2002). dl2 neurons that are derived from Ngn1-
expressing progenitor cells develop normally in Ngn1 mutants. In contrast, all dl2 
interneurons and spinal sensory ganglia are absent in Ngn1 and Ngn2 double mutants 
(Ma et al., 1999). In addition to controlling neurogenesis, Ngn2 has been found to control 
motoneuron differentiation. In Ngn2 null mice, motoneuron specification is compromised 
while motoneuron differentiation occurs normally in Ngn1 null mice (Scardigli et al., 
2001). Another group has also shown that Ngn2 coordinates with Olig2 and plays an 
important role in the induction of pan-neuronal and subtype-specific properties of 
motoneurons (Mizuguchi et al., 2001). The loss of Ngn2 with Ascl1 or alone also 
 




revealed yet another function for Ngn2 downstream of Ascl1 in modulating the number 
of Ascl1-dependent neurons (dl3 and dl5) that form (Helms et al., 2005).  
 
1.2.4.2.1.3 Achaete-scute complex-like 1   
Achaete-scute complex-like 1 (Ascl1) is a vertebrate homolog of the Drosophila 
proneural genes of the Achaete-scute complex (Johnson et al., 1990) that is expressed 
ventral to Ngn1 domain within the ventricular zone in distinct regions along the RC and 
DV axes of the developing neural tube (Guillemot et al., 1993; Ma et al., 1997; Torii et 
al., 1999).  
 
Ascl1 homozygous mutants provide evidence demonstrating its essential role in 
the development of CNS with arrestment in the development of neuronal precursors and 
subsequent sympathetic neurons (Guillemot et al., 1993). Later studies have also revealed 
a role for Ascl1 in inducing neuronal differentiation and specification in vitro (Farah et al., 
2000) and in the chick neural tube (Nakada et al., 2004). In addition, a loss or decrease in 
specific dorsal interneurons has also been observed in correlation with the loss of Ascl1 
function (Helms et al., 2005; Li et al., 2005). Ascl1 has been found to be necessary and 
sufficient for the generation of most dl3 and all of dl5 neurons while dl4 neurons are 
derived from low levels or no Ascl1 (Helms et al., 2005). Recent studies through the use 
of in vivo genetic fate mapping have provided evidence for another role for Ascl1 in the 
generation of lineage-restricted oligodendrocyte precursor cells at E16 after giving rise to 
dorsal horn interneurons at E11 (Battiste et al., 2007).  
 




1.2.4.2.1.4 Oligodendrocyte lineage transcription factor   
Oligodendrocyte lineage transcription factor 1 and 2 (Olig1 and Olig2) are first identified 
as Shh-induced genes encoding oligodendrocyte-specific bHLH transcription factors that 
promote oligodendrogenesis (Lu et al., 2000; Zhou et al., 2000). Oligodendrocytes in the 
CNS are responsible for myelinating cells that allows for increased complexity in 
structure and function of the nervous system in the vertebrates. In addition to 
ensheathment, oligodendrocytes maintain axonal integrity and are involved in signaling 
networks with neurons (Bergles et al., 2000). 
 
 During development, motoneuron formation from pMN progenitors is completed 
by E10.5 followed by oligodendrocyte production from E12.5. As Olig2 expression in the 
pMN domain is present well before the time of oligodendrocyte progenitors (OLPs) 
appearance, Olig2 is suggested to play a role in motoneuron specification. Indeed, several 
groups have shown that Olig2 is involved in motoneuron specification in the pMN 
domain (Takebayashi et al., 2000; Mizuguchi et al., 2001; Novitch et al., 2001). This 
switch from neuron to OLPs has been elegantly demonstrated with a mechanism that 
suggests a temporal shift in the gene expression patterns of Olig2’s regulatory partners 
such as Pax6 and the neurogenins (Mizuguchi et al., 2001; Novitch et al., 2001). Ngn2 is 
coexpressed with Olig2 at the onset of motoneuron generation and is downregulated at 
the time of oligodendrogenesis (Mizuguchi et al., 2001; Novitch et al., 2001; Zhou et al., 
2001). Mice with a homozygous inactivation of Olig2 did not feed and died on the day of 
birth. In addition,  analyses of their spinal cord showed no production of any 
 




oligodendrocytes and motoneurons are largely eliminated, providing evidence that a 
single gene mutation leads to the loss of two cell types (Takebayashi et al., 2002). 
Olig1/2 null mutants have also help to shed light on the specific roles that each Olig gene 
plays (Zhou and Anderson, 2002; Lu et al., 2002). Olig1 is required for the development 
and maturation of oligodendrocytes while Olig2 has roles in oligodendrocyte and 
motoneuron specification in the spinal cord.    
 
1.2.4.2.2. Homeobox genes 
Homeobox genes encode an evolutionarily conserved class of transcription factors called 
homeoproteins that have fundamental roles in developmental processes such as patterning, 
differentiation, migration and specification. Homeoprotein transcription factors contain a 
60 amino acid highly conserved structure called homeodomain that mediates binding to 
DNA, usually through the 50th residue, which is often glutamine (Gehring et al., 1994). 
Members of the Pax gene family are a subclass of the homeobox genes based upon the 
presence of other conserved domains such as the 128 amino acid paired conserved 
domains while the LIM homeodomain genes encode key regulators of developmental 
pathways that feature two LIM domains and a homeodomain. 
 
1.2.4.2.2.1 Pax2 
Paired-box-containing Pax genes were discovered through its homology to the paired box 
found amongst the Drosophila segmentation genes paired (prd), gooseberry-proximal 
(gsb-p), and gooseberry-distal (gsb-d) (Bopp et al., 1986). In 1990, two groups described 
 




the identification, primary structure and the expression pattern of Pax2 in the developing 
embryo (Dressler et al., 1990; Nornes et al., 1990). Initial studies have shown that Pax2 is 
broadly expressed in the intermediate region of the developing spinal cord (Nornes et al., 
1990; Puschel et al., 1992) and subsequently, Burrill and colleagues demonstrated that 
multiple interneuron cell types in the developing spinal cord express Pax2 (Burrill et al., 
1997). In addition, they show that Pax6 is required for the correct specification of ventral 
interneurons that express Pax2 and En1. In the dorsal horn of the developing spinal cord, 
Pax2 expression is found in dl4 and dl6 neurons (Helms and Johnson, 2003; Wilson and 
Maden, 2005) while ventral neurons V0 and V1 express Pax2 (Burrill et al., 1997).  
 
1.2.4.2.2.2 Islet 1 
Islet1 (Isl1) belongs to the family of LIM-homeodomain transcription factors which is a 
subdivision of the homeobox gene family (Dawid et al., 1995). The LIM domain, 
originally named after the first three proteins that were observed to have them, Lin 11, 
Isl1 and Mec3, is a cysteine rich domain that binds two zinc ions to form a finger-like 
structure (Michelsen et al., 1993; Perez-Alvarado et al., 1994; Konrat et al., 1997). Isl1 
was first cloned from the insulin-producing β cells in the pancreas (Karlsson et al., 1990) 
and their expression has been observed in various organs and tissues that include the 
kidney, inner ear, thyroid and spinal cord (Karlsson et al., 1990; Dong et al., 1991; Thor 
et al., 1991; Mitsiadis et al., 2003; Radde-Gallwitz et al., 2004).  
 
 




 The expression of Isl1 is the first molecular indicator of motoneuron 
differentiation (Karlsson et al., 1990; Ericson et al., 1992; Tsuchida et al., 1994). 
Together with four other additional LIM homeobox genes, Isl2, Lim3, Gsh4 and Lim1, 
they are implicated in delineating classes of motoneurons and organizing them in the 
spinal cord (Tsuchida et al., 1994; Li et al., 1994; Appel et al., 1995; Tokumoto et al., 
1995). The somatic and visceral motoneurons are two classes of motoneurons in the 
spinal cord that require the expression of Isl1 (Tsuchida et al., 1994; Pfaff et al., 1996). 
They migrate and settle in different regions of the spinal cord with distinct functions 
(Lichtman et al., 1980; Markham and Vaughn, 1991) and are generated from a common 
set of ventral progenitor cells (Ericson et al., 1997b; Briscoe et al., 1999; Briscoe et al., 
2000).  
 
The loss of Isl1 in null mutant mice revealed an important role that it plays in the 
developing spinal cord: motoneurons are notably absent and progenitor cells that are 
destined to undergo motoneuron differentiation are removed by apoptosis. Also, the 
population of En1-expressing interneurons (V1) fails to differentiate in the absence of 
Isl1 (Pfaff et al., 1996). In the dorsal neural tube, dl3 neurons are also defined by the 










1.2.4.2.3 Other molecular factors 
1.2.4.2.3.1 Brain Lipid-Binding Protein 
Brain lipid-binding protein (BLBP) is a member that belongs to a family of low 
molecular weight fatty acid-binding protein (FABP) (Kuhar et al., 1993; Feng et al., 
1994; Kurtz et al., 1994). With its high level of expression in the CNS during 
development, it has been implicated in molecular processes such as metabolism and 
signal transduction (Chytil and Ong, 1987; Dolle et al., 1989; Kurtz et al., 1994). A 
number of studies have also provided lines of evidence that a close correlation exist 
between BLBP expression and radial glial differentiation. BLBP has been observed to 
regulate glial cells in response to neurons (Feng and Heintz, 1995) and anti-BLBP 
antibodies have the ability to inhibit glial differentiation in response to neurons in mixed 
primary cultures. However, adhesions between neurons and glia are not affected (Feng et 
al., 1994). This is in agreement with previous studies that neurons play a role in 
regulating glial cell function and differentiation (Hatten, 1985; Hatten, 1987). 
 
 In the spinal cord, radial glia extend processes from the ventricular zone to the 
pial surface and aid in the guidance of differentiating and migrating neurons during 
neurogenesis before differentiating into astrocytes (Edwards et al., 1990; Culican et al., 
1990). Besides being astrocyte progenitors, radial glia also serve as neural progenitors in 
the CNS (varez-Buylla, 1990; Hartfuss et al., 2001; Noctor et al., 2002; Anthony et al., 
2004). Therefore, radial glia play a central role in the development of the CNS.   
 
 





The interest in Doublecortin (DCX) arises from the identification of a human disease 
with defects in neuronal migration called lissencephaly. Lissencephaly is caused by a 
defect in the DCX gene (des, V et al., 1998; Gleeson et al., 1998) and it exists as an X-
linked disease that is associated with epilepsy and mental retardation (Harding B., 1996). 
Several groups have demonstrated that DCX is a microtubule-associated protein that is 
widely expressed by migrating and differentiating neurons throughout the CNS and PNS 
during embryonic and postnatal development (Gleeson et al., 1999; Francis et al., 1999; 
Horesh et al., 1999; Couillard-Despres et al., 2001). Microtubules, together with 
neurofilaments and actin are dynamic proteins within neurons that can change in structure 
in the face of migration either along radial glia or independent of radial glia. DCX 
expression has been found to be limited to post-mitotic neuronal cells with a 
concentration at the extremities of growing neuronal processes. This localization and its 
association with microtubules suggest a role for DCX in the growth of neuronal processes 
which is downstream of directional signals (Friocourt et al., 2003).            
 
1.3 Development of dorsal root ganglia neurons 
Neural crest cells have a broad developmental potential and produce a huge array of 
derivatives (Le Douarin and Kalcheim, 1999). In the trunk, the development of sensory 
neurons as one particular neural crest derivatives forms the dorsal root ganglia (DRG). 
Early studies have demonstrated the contribution of neural crest cells to its development 
(Horstadius, 1950) and subsequently, another group has also confirmed these findings in 
 




amphibians (Weston, 1970). Besides neural crest cells, a population of migratory cells 
from the ventral neural tube (Sohal et al., 1996) and the boundary cap cells (a second 
population of neural crest-derived cells) (Maro et al., 2004) have also been implicated to 
contribute to sensory ganglia.   During the early stages, neural crest cells arise from the 
lateral margin of the neural plate, subsequently delaminate from the dorsal neural tube 
and neuroepithelium, generate multiple neural cell types and populate the peripheral 
nervous system (Le Douarin and Dupin, 2003). As the neural crest cells migrate along the 
medial pathway between the neural tube and somite, DRG precursors adopt a sensory fate 
next to the spinal cord. The DRG are organized as paired ganglia adjacent to each somite 
along the entire RC axis with neurons extending their peripheral processes that innervate 
skin, muscles and joints of the limbs and trunks. In addition, DRG neurons also extend 
central projections dorsally by entering the spinal cord through the dorsal root.        
 
 It has been shown that sensory neurons generally are divided into two broad 
categories based on cell body size: the large neurons that convey fine touch and 
proprioceptive information with myelinated fibers and the small neurons that convey pain 
information with unmyelinated fibers (Scott, 1992). These two classes of sensory neurons 
differ by their expression of neurotrophin receptors as well. Neurotrophin receptor 
mRNA TrkA is expressed in small diameter neurons while TrkC is expressed in large 
diameter neurons (Mu et al., 1993; Wright and Snider, 1995). Based on thymidine 
birthdating studies, it has been demonstrated that DRG growth in the avian (Carr and 
Simpson, Jr., 1978) and mammalian (Lawson and Biscoe, 1979) embryos occurs in two 
 




phases whereby large neurons are first generated followed by a population of large and 
small neurons.  
 
1.3.1 Sensory neuron specification 
Cumulative evidence has suggested that the bHLH transcription factors, Neurogenins, 
play an important role in the specification of neural precursors in the developing neural 
tube. In the development of the DRG, Neurogenins have also been shown to be necessary 
for the development of a subset of sensory neurons in knockout studies (Fode et al., 1998; 
Ma et al., 1998; Ma et al., 1999). In Ngn1 mutants, the number of large diameter neurons 
is reduced and small neurons are absent. In Ngn2 null embryos, there is a delayed 
expression of TrkC during the early stages. However, the development of the DRG 
appears normal during the later stages. In double mutant embryos, there is a complete 
loss of DRG neurons. These results suggest that each Ngn gene is necessary for the 
development of different population of precursors at different developmental stages.    
 
 Other secreted factors such as fibroblast growth factors (FGFs), Wnt and TGF-β 
families also play a role in specifying the fate of dorsal neural cells, notably neural crest 
cells. The ability of secreted FGFs to enhance generation of neural crest cells appears to 
be mediated by Wnt family members (LaBonne and Bronner-Fraser, 1998). Signals 
mediated by members of the TGF-β superfamily such as BMP-4 and BMP-7 can mimic 
the ability of epidermal ectoderm to induce neural crest formation in chick neural plate 
tissue (Liem, Jr. et al., 1997). Another transcription factor that is essential for the 
 




development and survival of sensory neurons in the trigeminal ganglion and DRG is the 
POU domain-containing Brn3a. Migrating sensory neurons undergoing their final cell 
division express Brn3a (Fedtsova and Turner, 1995) which is downstream of Ngn2, 
suggesting that Ngn2 may regulate Brn3a (Greenwood et al., 1999). In Brn3a null mutant 
mice embryos, sensory neurons are lost, thereby confirming the role that it plays in the 
development of the DRG (McEvilly et al., 1996; Xiang et al., 1996). 
 
1.4 Diabetic mouse models 
Historically in the field of diabetes research, the use of animals has been extensively 
employed. Animal model of hyperglycaemia was first discovered in the 1880s when the 
pancreas of a dog was removed. Subsequently, several more experiments were done with 
rabbits and dogs (Bliss, 2000). Removing the pancreas, either partially or totally, is one 
of the most straightforward ways of inducing hyperglycaemia in an animal. However, 
non-surgical methods of inducing hyperglycaemia by the administration of toxins such as 
streptozotocin (STZ) (Junod et al., 1969) and alloxan (Lenzen and Panten, 1988) also 
exist. These diabetogenic agents induce diabetes by selectively destroying the pancreatic 
β-cells and are thus valuable tools in studying the effect of gestational diabetes on the 
offspring (Van Assche et al., 1991; Merzouk et al., 2001; Caluwaerts et al., 2003) and the 
consequences of hyperglycaemia (Garcia-Marin et al., 1988; Reagan et al., 1999; Salgado 
et al., 2001; Yu et al., 2001). 
 
 




Alloxan was first described in 1818 and its diabetogenic properties and necrotic 
effect on pancreatic islets were reported much later in 1943 (Dunn et al., 1943). It was 
demonstrated to evoke a sudden rise in insulin secretion just after treatment in isolated 
islets (Weaver et al., 1978) and perfused rat pancreas (Kliber et al., 1996). This rise in 
insulin secretion did not evoke a significant reduction of blood glucose, thus suggesting 
insulin insensitivity following alloxan treatment (Kliber et al., 1996; Szkudelski et al., 
1998). One of the important factors in alloxan diabetogenicity results from the formation 
of reactive oxygen species (Heikkila et al., 1976) that targets DNA fragmentation in the β 
cells of pancreatic islets (Takasu et al., 1991; Sakurai and Ogiso, 1995).  
 
 STZ is an analogue of N-acetyglucosamine (GlcNAc) that is synthesized by 
Streptomycetes achromogenes and is originally identified as an antibiotic (Breyer et al., 
2005). It was soon recognized to induce IDDM in animals through rapid uptake into 
pancreatic β cells by glucose transporter 2 (GLUT2) as reduced expression of GLUT2 
has been observed to prevent the diabetogenic action of STZ (Schnedl et al., 1994; 
Thulesen et al., 1997). STZ has been found to decrease insulin biosynthesis and secretion 
(Bolaffi et al., 1987; Nukatsuka et al., 1990) and impair glucose oxidation (Bedoya et al., 
1996). However, the main reason for its diabetogenic action lies in its ability to induce β 
cell apoptosis through alkylation of DNA (Delaney et al., 1995; Elsner et al., 2000). 
Although the dosage range of STZ is not as narrow as alloxan, increasing the dosage can 
cause greater non-specific cytotoxicity in mice and rats that leads to acute kidney tubule 
damage (Paigen et al., 1987; Iyengar et al., 2003). Thus, giving multiple low-dose 
 




injections that is used predominantly in the mouse can lower the non-specific cytotoxicity 
to a negligible level (Seaquist et al., 1989).  
  
Maternal diabetes-induced congenital malformations experiments conducted in 
the early 1950s and 1960s with diabetic mouse models have demonstrated that the results 
are relevant to malformations in human diabetic pregnancies (Bartelheimer and Kloos, 
1952; Ross and Spector, 1952; Watanabe and Ingalls, 1963). Since then, numerous 
studies have reported the use of STZ-induced diabetic mouse models in a bid to 
understand congenital malformations and its possible mechanisms in maternal diabetes 
(Fine et al., 1999; Liao et al., 2004; Wentzel et al., 2005; Fu et al., 2006). 
 
1.5 Hypotheses and objectives 
Maternal diabetes has been widely demonstrated to induce embryopathy which is 
characterized by congenital malformations in various organs in embryos of humans and 
in rodent models of diabetic pregnancy (Becerra et al., 1990; Phelan et al., 1997; Langer 
and Conway, 2000; Aberg et al., 2001; Cederberg et al., 2003; Liao et al., 2004). Neural 
tube defects (NTDs) including spina bifida, exencephaly and anencephaly have been 
frequently reported in embryos of diabetic pregnancies. NTDs are severe disabling or 
life-threatening congenital abnormalities which mainly exhibit incomplete fusion of the 
neural plate at the dorsal midline along the entire rostro-caudal length of the neural tube. 
Over the years, several studies attempted to unravel the molecular mechanisms by which 
maternal diabetes induces NTDs. Recently, maternal diabetes in vivo or high glucose in 
 




vitro has been shown to alter the expressions of several genes involved in neural tube 
development, subsequently contributing to NTDs (Fine et al., 1999; Liao et al., 2004; Fu 
et al., 2006).  
 
 During neurulation in embryos, the neural plate derived from ectoderm undergoes 
folding and shaping, and subsequently fuses at the midline to form the neural tube which 
gives rise to the brain and spinal cord. The patterning of the neural tube along its 
dorsoventral axis is regulated by two different classes of proteins in an antagonistic 
manner. Sonic hedgehog (Shh), a secreted protein synthesized by the notochord and floor 
plate, functions as a ventralizing signal (Roelink et al., 1994; Marti et al., 1995b; Chiang 
et al., 1996). The establishment of a ventral-to-dorsal decreasing concentration of SHH 
activity controls neuronal fate by either inducing or repressing the expression of several 
progenitor cell homeodomain transcription factors (Ericson et al., 1997b). During the 
early stages of ventral neural tube development, three main classes of cells such as floor 
plate cells, a specialized class of glial cells at the ventral midline, interneurons and 
motoneurons are generated at more dorsal positions to the floor plate. Motoneurons 
which express Isl1, a homeodomain transcription factor populate the ventral spinal cord 
(Pfaff et al., 1996). Interneurons that project and wire the local circuit (Brown, 1981), are 
crucial in integrating motor output. Earlier studies have demonstrated that Pax2, a paired-
box transcription factor, is expressed in multiple interneuron cell types (Burrill et al., 
1997). The interneurons and ventral neurons have been divided into 5 domains, with each 
 




domain being characterized by distinct gene expression markers (Wilson and Maden, 
2005).  
 
Cells lateral to the roof plate differentiate into several classes of dorsal sensory 
interneurons. Experimental studies suggest that the roof plate is a source of inductive 
signals that control the generation of interneurons in the dorsal spinal cord (Liem, Jr. et 
al., 1997). There are 6 groups of dorsal interneurons, dl1-dl6, in the dorsal half of the 
spinal cord. These neurons are derived from progenitors that are indicated by the 
expression of basic helix-loop-helix (bHLH) proteins Atoh1, Neurogenin1 (Ngn1), 
Neurogenin2 (Ngn2) and Ascl1 (Lee et al., 1998a; Lee et al., 2000; Helms and Johnson, 
2003). These neurons connect sensory input from the periphery to spinal cord 
motoneurons and higher centres. It is hypothesized that defective development of the 
sensory and motoneurons may impair the circuitry and functions of the nervous system. 
 
We have previously demonstrated that maternal diabetes alters the expression of 
some genes involved in neural tube development (Liao et al., 2004; Fu et al., 2006), 
resulting in severe malformations of the neural tube. Embryos from diabetic mice exhibit 
several forms of neural tube defects including non-closure of the caudal neural tube. The 
objective of this study is to analyze the expression pattern of genes that are involved in 
the generation of distinct neuronal populations along the DV axis during caudal neural 
tube development in embryos of diabetic mice. As the open neural tubes of embryos from 
diabetic mice fail to fuse at the dorsal midline, it is hypothesized that the expression of 
 




roof plate signals is altered, thus affecting specification of neuronal precursors in the 
developing neural tube. The development of the PNS during embryogenesis is also 
important as key connections enable the processing of information between the external 
environment and the CNS. Sensory information from the external environment is 
transmitted to the CNS via receptors associated with the DRG. Since the development of 
sensory neurons depends heavily on signals from the dorsal neural tubes, and as the 
neural tube development is impaired in embryos of diabetic pregnancy, it is hypothesized 
that the development of DRG is also impaired in those embryos. The development of the 
peripheral sympathetic ganglion neurons that make up the sympathetic chains in the PNS 
will also be analyzed.   
 
1.5.1 The specific aims of this study are as follows: 
1. To analyze the morphology of caudal neural tubes and sensory neurons of DRG in 
embryos of diabetic mice by histology using haematoxylin and eosin (H&E) staining. 
2.     To analyze the development of various cell types including motoneurons, 
interneurons, oligodendrocytes, migrating neurons and radial glial cells in embryos of 
diabetic mice with specific molecular markers by immunohistochemistry, real time 
RT-qPCR and in situ hybridization.  
3.     To analyze the expression patterns of genes that are involved in the generation of 
distinct neuronal populations along the DV axis during caudal neural tube 
development in embryos of diabetic mice by in situ hybridization and real time RT-
qPCR. 
 




4.      To investigate the proliferation index in the caudal neural tube and apoptosis in DRG 
sensory neurons of embryos from diabetic and normal mice by immunohistochemical 
detection of BrdU incorporation and TUNEL assay, respectively. 
5. To examine the post-mitotic neurons in the DRG with Tuj1, a neuron-specific 
cytoskeletal component.   
6.     To examine the development of the sympathetic chains in embryos from diabetic 
mice by immunohistochemistry with tyrosine hydroxylase, a marker of peripheral 
sympathetic ganglion neurons. 
  
The analysis of the development of different cell types and gene expression profiles 
may help to provide a clue for changes in molecular signals contributing to caudal neural 
tube defects in embryos of diabetic mice. This may provide better insights into the 
development of therapeutic options for fetal deformities in diabetic pregnancy and the 
determination of biomarkers to identify the possible fetal deformities in utero. 
 
 


















MATERIALS AND METHODS 
 
 




2.1 Experimental animals 
8-10 weeks old Swiss Albino mice were purchased from the Laboratory Animals Centre 
(National University of Singapore, Singapore) and housed in clean cages in a 
temperature-controlled room with 14 hours light and 10 hours dark schedule with food 
and water ad libitum. The numbers of embryos (control group and diabetic group with 
open neural tube) collected for experiments are listed in Table 1. All procedures 
involving animal handling were in accordance with guidelines of the Institutional Animal 
Care and Use Committee (IACUC), National University of Singapore. 
 
Table 1. Embryos used in this study 
Sex No. of Mice No. of embryos Age Experiments 
Female 
5 from normal pregnancy 56 
E11.5 H&E staining 
5 from diabetic pregnancy 4* out of 38 
Female 8 from normal pregnancy  78 E11.5 IHC, ISH 
105from diabetic pregnancy 64* out of 630 
Female 2 from normal pregnancy 23 E11.5 Real time RT-qPCR 
18 from diabetic pregnancy 10* out of 102 
Female 2 from normal pregnancy 19 E8.5 ISH 
2 from diabetic pregnancy 15 
Male 35 - - Used for mating 
*denotes embryos with open neural tube phenotype; E: embryonic day; IHC: 
Immunohistochemistry; ISH: In situ hybridization 
 
2.2 Induction of diabetes mellitus in mice 
Streptozotocin (STZ) (Cat. No. S0130, Sigma-Aldrich, USA) 
2.2.1 Materials  
 
 




0.01M sodium citrate buffer: 
Distilled water  50ml 
Sodium citrate   1.47g 
The pH was adjusted to 4.5 by adding 0.01M citric acid. 
 
Insulin-dependent diabetes mellitus was induced in 8-10 weeks old Swiss Albino mice by 
intraperitoneal injection of STZ (80mg/kg body weight, Sigma-Aldrich, St. Louis, MO, 
USA) on three successive days. STZ was dissolved in freshly prepared 0.01M citrate 
buffer (pH 4.5) at a concentration of 10mg/ml. STZ is a diabetogen, selectively 
destroying β-cells of pancreatic islets.  
2.2.2 Procedure 
 
2.3 Blood glucose test 
Blood glucose levels in the mice were monitored 1 week after STZ injection. The tip of 
the tail was pricked with a 27G needle and a drop of blood was placed on a blood glucose 
strip which was inserted into a glucometer (Roche Diagnostics, Basel, Switzerland). Only 
mice with non-fasting blood glucose levels exceeding 20mmol/l were classified as 
diabetic and used in the experiment. Blood glucose levels in age-matched control mice 













0.1M phosphate buffer (pH7.4): 
NaH2PO4.H2O   2.76g 
Na2HPO4.2H2O   14.24g 
Approximately 800ml of distilled water were added and the pH was adjusted to 7.4 with 
1N hydrochloric acid (HCl) solution before adjusting the final volume to 1 liter. 
 
4% paraformaldehyde (PF): 
Paraformaldehyde (Sigma)    4g 
0.1M phosphate buffer (pH 7.4)   100ml 
 
0.1M phosphate-buffered saline (PBS): 
Di-sodium hydrogen phosphate heptahydrate 13.3g 
Sodium chloride     8.5g 
Approximately 800ml of distilled water were added and the pH was adjusted to 7.4 with 
1N HCl solution before adjusting the final volume to 1 liter. 
 
0.1M phosphate buffer with 20% sucrose: 
Sucrose       20g 
 




0.1M phosphate buffer (pH 7.4)   100ml 
 
Diabetic female mice were time-mated with age-matched male mice showing normal 
blood glucose level (4-7mmol/l). Noon on the day when a copulation plug was observed 
was counted as embryonic day 0.5 (E0.5). Embryos were collected by Caesarean section 
from pregnant mice anaesthetized with pentabarbitol (100mg/kg body weight) on E11.5. 
Embryos with an open neural tube phenotype from diabetic mice and normal embryos 
from non-diabetic mice were used as experimental and control groups respectively. 
2.4.2 Procedure 
 
 All fixatives were freshly prepared before use. The 4% PF solution was prepared 
by heating paraformaldehyde powder in 0.1M phosphate buffer (pH 7.4). It was 
subsequently cooled in ice before use. The whole embryos were fixed in 4% PF and 
cryoprotected with 20% sucrose in phosphate buffer at 4°C overnight. The images of 
whole embryos were captured using a stereomicroscope (Nikon SMZ1500; Nikon, Japan) 
fitted with a camera. Embryos for haematoxylin & eosin (H&E) staining were fixed in 
10% formalin indefinitely. 
 









20% methanol in 0.1M PBS 
50% methanol in 0.1M PBS 
80% methanol in 0.1M PBS 
 
Embryos fixed in 4% PF overnight were washed three times with 0.1M PBS. Embryos 
were then dehydrated in an ascending series of methanol (20%, 50%, 80% methanol in 
0.1M PBS) before storage in 100% methanol at -80°C. Prior to using the embryos in 
experiments, dehydrated embryos were rehydrated in a descending series of methanol 




Haematoxylin                        
2.6.1 Materials 
Eosin 





70% ethanol  200ml 
 




Concentrated HCl 500µl 
1.5% gelatin solution: 
Gelatin   7.5g 
Chrome Alum  0.75g 
Distilled water  500ml 
Gelatin, chrome alum and distilled water were combined in a beaker and heated till 
dissolved. Gelatin solution was cooled to room temperature and filtered with a 
Whatman’s filter paper.  
 
Silane solution: 
(3-aminopropyl) triethoxysilane  7ml 
Absolute alcohol    343ml 
 
Preparation of gelatinized slides: The slides were cleaned by soaking in absolute 
alcohol for 1 minute with agitation and air-dried. Dried slides were dipped in the gelatin 
solution for 1 minute and then drip-dried at room temperature. Gelatinized slides were 
kept in a 37ºC oven for future use.   
2.6.2 Procedure 
Preparation of silanized slides: The slides were cleaned by soaking in absolute alcohol 
for 1 minute with agitation and air-dried. Dried slides were dipped in the silane solution 
 




for 5 minutes, washed twice with distilled water and dried in a 60ºC oven. Silanized 
slides were kept in a 37ºC oven for future use.   
Paraffin sectioning: Embryos that were fixed in 10% formalin were dehydrated in an 
ascending series of alcohol (50%, 70%, 80%, 90% ethanol in distilled water) for 20 
minutes each. Embryos were immersed in equal parts of alcohol and toluene for 75 
minutes before immersing them in two changes of toluene for an hour each. Finally, 
embryos were infused with molten paraffin wax under vacuum for 1 hour and embedded 
into paraffin blocks. Paraffin sections of 5µm thickness were cut on a microtome (Leica 
RM 2165; Leica Microsystems, Germany) and mounted from a 40°C water bath onto 
slides and dried on a heating plate.  
Cryosectioning: Embryos that were fixed overnight in 4% PF in PBS were cryoprotected 
with 20% sucrose at 4°C overnight. Embryos with neural tube defects from diabetic mice 
and normal embryos from non-diabetic mice were mounted on metal chucks using M-1 
embedding matrix (Lipshaw; Pittsburgh, USA) and rapidly frozen by quenching in liquid 
nitrogen. Transverse sections of 20µm thickness were cut through the caudal neural tube 
using a cryostat (Leica CM 3050; Leica Microsystems, Germany). The sections were 
subsequently mounted on gelatinized slides and allowed to dry at room temperature for 2 
hours. For TUNEL analysis, sections were mounted on silanized slides and allowed to 
dry at room temperature for 2 hours.   
Haematoxylin and Eosin (H&E) staining: For morphological analyses, sections were 
stained with H & E.  Paraffin sections on slides were dewaxed with 2 changes of xylene 
and hydrated with a descending series of ethanol (90%, 70% and 50% ethanol in water). 
 




Sections were rinsed in deionized water before staining with haematoxylin for 10 minutes 
at room temperature. Differentiation was achieved by dipping the sections in a 
differentiating fluid for about 25 seconds.  The sections were washed in deionized water 
and counter-stained with aqueous eosin for 5 minutes. Finally, the sections were rinsed 
with deionized water and dehydrated in 90% ethanol followed by 3-4 changes of absolute 
ethanol and 3 changes of xylene before being mounted with Permount.  
 
2.7 Fluorescent immunohistochemistry 
Immunohistochemistry bridges three disciplines namely histology, immunology and 
chemistry and exploits the fundamental basis of antibodies binding specifically to 
antigens in biological tissues. The beginning of immunohistochemistry started with an 
article describing the technique for detecting cellular antigens in tissue sections (Coons et 
al., 1941) and subsequently, technical advances in the field established various sensitive 
detection systems that uses enzymes, metals and fluorescent compounds conjugated to 
antibodies (Taylor et al., 2002). Antibodies that are tagged with fluorophores such as 
FITC, Cy3 and Rhodamine can then be visualized with the highly sensitive confocal laser 









Mouse anti-Isl1 monoclonal antibody (Cat. No. 39.4D5, DSHB, University of Iowa, 
USA) 
2.7.2 Materials 
Rabbit anti- Pax2 polyclonal antibody (Cat. No. PRB276P, Covance, CA, USA) 
Rabbit anti-class III β-Tubulin (Tuj1) polyclonal antibody (Cat. No. PRB435P, Covance, 
CA, USA) 
Goat anti-Olig2 polyclonal antibody (Cat. No. AF2418, R&D Systems, MN, USA) 
Guinea pig anti-doublecortin polyclonal antibody (Cat. No. AB5910, Chemicon, USA) 
Guinea pig anti-glutamate transporter (Glast) polyclonal antibody (Cat. No. AB1782, 
Chemicon, USA) 
Rabbit anti-brain lipid-binding protein (Blbp) polyclonal antibody (Cat. No. AB9558, 
Chemicon, USA) 
Rabbit anti-tyrosine hydroxylase polyclonal antibody (Cat. No. PRB515P, Covance, CA, 
USA) 
Vector M.O.M blocking reagent (Cat. No. MKB2213, Vector Laboratories, USA) 
Cy3-conjugated sheep anti-mouse IgG (Cat. No. C2181, Sigma-Aldrich, USA) 
Cy3-conjugated sheep anti-rabbit IgG (Cat. No. C2306, Sigma-Aldrich, USA) 
Biotinylated goat anti-rabbit IgG (Cat. No. BA1000, Vector Laboratories, USA) 
Biotinylated goat anti-guinea pig IgG (Cat. No. BA7000, Vector Laboratories, USA) 
Biotinylated rabbit anti-goat IgG (Cat. No. BA5000, Vector Laboratories, USA) 
Fluorescein Avidin D (Cat. No. A2001, Vector Laboratories, USA) 
Sheep serum (Cat. No. X050320, Dako, Denmark) 
 




Goat serum (Cat. No. S1000, Vector Laboratories, USA) 
Rabbit serum (Cat. No. S5000, Vector Laboratories, USA) 
4’, 6- diamidino-2-phenylindole dihydrochloride (DAPI) (Cat. No. D1306, Molecular 
Probes, USA) 
Fluorescent Mounting Medium (Cat. No. S302380, Dako, Denmark) 
0.1M phosphate-buffered saline (PBS) 
4% paraformaldehyde (PF) 
 
0.1M PBS containing 0.1% Triton-X 100 (PBS-TX): 
Triton-X 100  1ml 
0.1M PBS  999ml 
 
For immunohistochemistry, tissue sections were incubated with various primary 
antibodies overnight at 4°C. Primary antibodies used mouse monoclonal anti-Isl1 (1:1000; 
DSHB, maintained by The University of Iowa) for motoneurons, rabbit polyclonal anti-
Pax2 (1:200) for interneurons, goat polyclonal anti-Olig2 (1:800) for oligodendrocytes, 
rabbit polyclonal anti-Tuj1 (1:2000) for post-mitotic neurons, guinea pig anti-
doublecortin (1:1000) for migrating neurons, guinea pig anti-glast (1:4000) and rabbit 
anti-blbp (1:3000) for radial glial cells and rabbit anti-tyrosine hydroxylase (1:3000) for 
sympathetic ganglia. Sections were washed with PBS-TX and incubated with appropriate 
Cy3-conjugated secondary antibodies (1:200) or biotinylated secondary antibodies (1:200) 
2.7.3 Procedure 
 




for 1 hour at room temperature. For tissues incubated with Cy3-conjugated secondary 
antibodies, sections were washed with PBS-TX, stained with DAPI (1µg/ml) for 5 
minutes and mounted with fluorescent mounting medium. For tissues incubated with 
biotinylated secondary antibodies, it is followed by incubation with avidin-conjugated 
fluorescein (1:300) for 30 minutes. Sections were washed, stained with DAPI (1µg/ml) 
for 5 minutes and mounted with fluorescent mounting medium. Photomicrographs were 
taken with an Olympus FV1000 confocal microscope (Olympus, Tokyo, Japan). The 
percentage of motoneurons and interneurons in relation to total cell number was 
determined from 8 sections (two each from 4 embryos of different litters) from each 
group.  
 
2.8 TdT-mediated dUTP nick end labeling (TUNEL) assay  
Apoptosis is a regulated form of cell death that is characterized by cell shrinkage, 
condensation of chromatin, membrane blebbing and fragmentation of DNA (Kerr et al., 
1972). Apoptosis play an important physiological role during development and normal 
homeostasis and has been associated with the pathogenesis of a long list of diseases such 
as AIDS, neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s 
disease (Thompson, 1995). In addition, apoptosis is a feature of many malignancies that 








 In the early stages, apoptosis is coupled with extensive DNA damage that may 
yield double-stranded and single-stranded DNA breaks known as nicks. These DNA 
nicks can be identified with end-labeling the free 3’-OH termini with modified 
nucleotides using the terminal deoxynucleotidyl transferase (TdT) as the enzyme in a 
reaction. This sensitive and fast method has been termed TUNEL (TdT-mediated dUTP 
nick end labeling) and is frequently used in the detection of apoptotic cells (Gavrieli et al., 
1992).  
 
In situ cell death detection kit (Cat. No. 11684795910, Roche Applied Science,  
Germany) 
2.8.2 Materials 
Fluorescent Mounting Medium (Cat. No. S3023, Dako, Denmark) 






Sodium citrate  0.05g 
Triton X-100  0.05ml 
Distilled water was added to make up to 1 liter.  
 
 




Detection of apoptotic cells in tissue sections by TUNEL was performed with the in situ 
death detection kit according to manufacturer’s instructions. Cryosectioned tissues on 
silanized slides were washed with PBS and incubated with permeabilization solution for 
2 minutes on ice. Slides were rinsed with PBS and subsequently incubated for 1 hour at 
37 °C in the dark with the TUNEL reaction mixture containing terminal deoxynucleotidyl 
transferase and fluorescein-labeled nucleotides. Finally, the slides were rinsed with PBS 
and incubated with DAPI (1µg/ml) for 5 minutes to stain the nuclei of all cells and 
mounted with fluorescent mounting medium. Photomicrographs were taken with an 
Olympus FV1000 confocal microscope (Olympus, Tokyo, Japan) and TUNEL-positive 
apoptotic cells were counted and the data have been presented as the percentage of 
TUNEL cells relative to the total number of cells.  
2.8.3 Procedure 
 
2.9 Analysis of cell proliferation by BrdU labeling  
Cell proliferation is an important aspect of all biological processes that involves DNA 
replication before the cells are divided. This close association is the basis for 
investigating cell proliferation with assays that measure DNA synthesis. Traditionally, 
radiolabeled nucleosides such as tritiated thymidine ([3H]-TdR) are incorporated into 








 5-bromo-2’-deoxy-uridine (BrdU) is a synthetic analog of thymidine that gets 
incorporated into DNA during the S phrase of the cell cycle. The incorporated BrdU can 
be detected immunohistochemically with anti-BrdU antibody (Porstmann et al., 1985) 
and cell proliferation index can be quantified in relation to the total number of cells. 
BrdU incorporation is a favorable alternative as it circumvents the disadvantages 
associated with [3H] thymidine uptake such as handling of harmful radioisotopes while 
retaining sensitivity.  
 
5-bromo-2-deoxyuridine (BrdU) (Cat. No. B5002, Sigma-Aldrich, USA) 
2.9.2 Materials 
Mouse anti-BrdU monoclonal antibody (Cat. No. B2531, Sigma-Aldrich, USA) 
Vector M.O.M blocking reagent (Cat. No. MKB2213, Vector Laboratories, USA) 
Cy3-conjugated sheep anti-mouse IgG (Cat. No. C2181, Sigma-Aldrich, USA) 
4’, 6- diamidino-2-phenylindole dihydrochloride (DAPI) (Cat. No. D1306, Molecular 
Probes, USA) 












For analysis of cell proliferation in the caudal neural tube, pregnant mice from both 
groups (n=5 in each group) were injected intraperitoneally with BrdU (100mg/kg body 
weight, Sigma-Aldrich, USA) 2 hours before the embryos were collected by Caesarean 
section. Embryos were fixed in 4% PF and cryoprotected with 20% sucrose at 4°C 
overnight. Transverse sections of 20µm thickness were cut through the caudal neural tube 
using a cryostat (Leica CM 3050; Leica Microsystems, Germany) and mounted on 
silanized slides and allowed to dry at room temperature for 2 hours. Sections were 
washed with PBS-TX after incubation with 2N HCl at 37°C for 30 minutes, blocked with 
Vector Mouse On Mouse (M.O.M) blocking reagent (Vector Laboratories, USA) for 1 
hour and incubated with mouse monoclonal anti-BrdU (1:1000; Sigma-Aldrich, USA) at 
4°C overnight. Sections were washed and incubated with cy3-conjugated sheep anti-
mouse secondary antibody (1:200; Sigma-Aldrich, USA) for 1 hour, washed with PBS 
and counter-stained with DAPI (1µg/ml) for 5 minutes before mounting with fluorescent 
mounting medium.  Photomicrographs were taken with an Olympus FV1000 confocal 
microscope (Olympus, Tokyo, Japan) and the percentages of BrdU positive cells in 
relation to total cell number in the neural tubes were determined from 10 sections (two 
each from 5 embryos) from each group. The proliferation index has been expressed as 










2.10 Whole mount in situ hybridization 
In situ hybridization (ISH) is a unique technique that enables the study of gene expression 
in cytological preparations and tissue sections in situ. First described in 1969 (Gall and 
Pardue, 1969), rapid advances have refined ISH and made it an important tool in clinical 
diagnostics and scientific research. The method involves hybridizing specific DNA or 
RNA probes that has been labeled to complementary target DNA or RNA sequences. 
Detection of these hybrids can be either by histochemical chromogen development for 
nonisotopically labeled probes or by radioautography if radiolabeled probes are used.   
2.10.1 Principle 
 
 Radioactive probes are being used with decreasing frequency as they have several 
drawbacks that include safety and disposal problems and long exposure time. Presently, 
digoxygenin and biotin are reporters that are commonly used in ISH. Digoxygenin-
labeled probes are more popular than the biotin-labeled ones as they have higher 
sensitivity and less background staining (Komminoth et al., 1992). To visualize the 
signals from these digoxygenin-labeled probes, antidigoxygenin antibody fragment 
conjugated to alkaline phosphatase or horseradish peroxidase is used in conjunction with 
appropriate substrates to yield insoluble-colored products. Whole mount ISH refers to 









Plasmids containing cDNA of mouse achaete-scute complex-like 1 (Ascl1), mammalian 
atonal homolog 1 (Atoh1), neurogenin 2 (Ngn2) (kindly provided by Dr. Francois 
Guillemot, UK) were amplified by E.coli transformation. Mouse neurogenin 1 (Ngn1), 
oligodendrocyte lineage transcription factor 2 (Olig2), sonic hedghog (Shh) and 
Wingless-related MMTV integration site (Wnt1) antisense probes were made from 
plasmids containing the coding region of each gene. Taq-polymerase-amplified PCR 
products of the coding regions of each gene were directly cloned into the polylinker site 
of the pCR2.1-TOPO vector (Invitrogen, CA, USA) and amplified by E.coli 
transformation. 
2.10.2 Preparation of cRNA probes 
 
2.10.3 Preparation of competent cells 
TFB1 solution: 
2.10.3.1 Materials 
KAc    0.294g 
KCl    0.745g 
CaCl2.2H2O   0.147g 
Glycerol   15ml 
1M MnCl2.2H2O  5ml 
Solution was made up to 95ml with distilled water and autoclaved before adding filter-
sterilized MnCl2. 2H2O. 
 
 





0.02M NaMOPS, pH 7 2ml 
CaCl2.2H2O   0.221g 
KCl    0.015g 
Glycerol   3ml 
Solution was made up to 20ml with distilled water and autoclaved. 
 
Luria-Bertani (LB) medium: 
Trypton  10g 
Yeast extract  5g 
NaCl   10g 
H2O   1L 
LB medium was purchased from the NUMI store of the National University of 
Singapore. 
 
DH5α strain of E. coli was streaked onto pre-warmed LB plate and incubated at 37ºC 
overnight. The following day, a single clone was picked and inoculated into 10ml LB 
medium and shaken at 220rpm in an orbital shaker (Forma, USA) at 37ºC overnight. The 
overnight culture was upscaled to 500ml LB in a 2 liter conical flask at 37ºC, and shaken 
at 220rpm till the OD=0.6 (λ=600) was achieved. The flask of cells was placed in ice 
water and shaken to ensure rapid cooling. The cells were centrifuged at 3000rpm for 15 
2.10.3.2 Procedure 
 




min at 4ºC in 10 pre-chilled tubes and the pellet was re-suspended in 10ml of ice-cold 
TFB1 solution. The re-suspended cells were centrifuged at 3000rpm for 8 minutes at 4ºC. 
The pellet was re-suspended in 2ml of TFB2 solution, aliquoted (200µl/tube) and rapidly 
immersed into liquid nitrogen, and stored in a -80ºC freezer. 
2.10.4 Transformation of competent cells with plasmid 
Plasmid mini kit (Cat. No. 12123, Qiagen, Germany) 
2.10.4.1 Materials 
Plasmid midi kit (Cat. No. 12143, Qiagen, Germany) 
 
Plasmid (5µl) was added into 50µl of competent cells and incubated on ice for 30 
minutes. Cells were heat shocked at 42ºC for 35 seconds and chilled on ice for 1 minute. 
To aid cell recovery, LB medium (500µl) was added to tube and shaken in an orbital 
shaker at 220rpm for 1 hour at 37ºC. The cell suspension was spread evenly on selective 
LB plates with 100µg/ml of the antibiotic ampicillin and incubated inverted at 37ºC 








 Two colonies were selected and each of them was transferred into separate tubes 
containing 5ml of LB medium with 100µg/ml ampicillin, and the tubes were shaken at 
220rpm at 37ºC overnight. Cells from 4ml of E. coli culture were harvested through 
centrifugation and the plasmids were extracted using a plasmid mini kit (Qiagen, 
Germany). The plasmid incorporation was confirmed with restriction enzyme analysis 
and sequence was confirmed with DNA sequencing.    
 1ml of E. coli culture from the confirmed colony was inoculated into a conical 
flask containing 100ml of LB with 100µg/ml of ampicillin and shaken at 220rpm at 37ºC 
overnight. The cells were harvested through centrifugation and the plasmids were 
extracted using a plasmid midi kit (Qiagen, Germany). 
 
2.10.5 Linearization of plasmid 
Restriction enzymes (Promega, USA) 
2.10.5.1 Materials 
Tris-saturated phenol (pH 8.0) 
Chloroform 
Isoamyl alcohol 
3M sodium acetate (pH 5.2) 
70% ethanol 
RNase-free distilled water (Gibco, USA) 
 




Plasmids were linearized with specific restriction enzymes in preparation for ‘run off’ 
transcription with RNA polymerases. Restriction digestions were performed at 37ºC for 2 
hours in a 200µl reaction containing 10µg of plasmid DNA with 50 Units of restriction 
enzyme and 1X buffer. Linearized templates were extracted in an equal volume of 
phenol : chloroform : isoamyl alcohol mixture (25 : 24 : 1), vortexed and centrifuged at 
5800rpm for 10 minutes. The aqueous upper layer was transferred to a new tube and 
extracted with chloroform : isoamyl alcohol mixture (1 : 1), vortexed and centrifuged 
again at 5800rpm for 10 minutes before transferring the aqueous upper layer to another 
new tube. The DNA was precipitated with one ninth volume of 3M sodium acetate (pH 
5.2) and 2 volume of ethanol at -80ºC for 1 hour. After centrifugation at 12,000rpm for 
15 minutes at 4°C, the pellets were washed with 70% ethanol, dried and dissolved in 
RNase-free distilled water.  
2.10.5.2 Procedure 
 
2.10.6 In vitro transcription 
2.10.6.1 Materials
DIG RNA labeling mix (Cat. No. 11 277 073 001, Roche Applied Science, Germany)  
   
T3 RNA polymerase (Cat. No. 11031163001 , Roche Applied Science, Germany) 
T7 RNA polymerase (Cat. No. 10881767001,  Roche Applied Science, Germany) 
Sp6 RNA polymerase (Cat. No. 10810274001, Roche Applied Science, Germany) 
 




RNase inhibitor (Cat. No. 03335399001, Roche Applied Science, Germany) 
0.1M DTT (Cat. No. P1171, Promega, USA) 
DNaseI, RNase-free (Cat. No. 10776785001, Roche Applied Science, Germany) 
RNase-free distilled water (Gibco, USA) 




The transcription reaction components were added on ice to give a final 20µl volume of 
reaction mix containing 1µg of linearized DNA, 2µl of 10X Transcription buffer, 2µl of 
Dig RNA labeling mix, 2 µl of 0.1M DTT, 40 Units of RNase inhibitor, 40 Units of 
T3/T7/SP6 RNA polymerase and RNase-free distilled water. The reaction mix was 
incubated at 37ºC for 2 hours before adding 2µl of DNase I to remove template DNA at 
37ºC for 15 minutes. The reaction was stopped with 2µl of 0.2M EDTA. RNA transcripts 
were precipitated with one tenth volume of 4M LiCl and 2.5 volumes of pre-chilled 
ethanol at -80ºC for 1 hour. The precipitated transcripts were collected by centrifugation 
at 11,800rpm at 4°C for 15 minutes, washed with 70% ethanol and dried. RNA 
transcripts were dissolved in RNase-free distilled water before diluting to a final 








2.10.7 Whole mount in situ hybridization 
Anti-digoxygenin-AP, Fab fragments (Cat. No. 11093274910, Roche Applied Science, 
Germany) 
2.10.7.1 Materials 
5-bromo-4-chloro-3-indoly phosphate (BCIP) (Cat. No. 10760 994001, Roche Applied 
Science, Germany) 
Nitro blue tetrazolium (NBT) (Cat. No. 1706532, Bio-Rad, USA)  
Denhardt’s solution (Cat. No. 30915, Sigma-Aldrich, USA) 
Formamide (Cat. No. 47671, Sigma-Aldrich, USA) 
Heparin (Cat. No. H3393, Sigma-Aldrich, USA) 
Yeast tRNA (Cat. No. R8759, Sigma-Aldrich, USA) 
Blocking reagent (Cat. No. 11096176001, Roche Applied Science, Germany) 
Proteinase K (Cat. No. P6656, Sigma-Aldrich, USA) 
Levamisole solution (Cat. No. SP5000, Vector Laboratories, USA) 
0.45µm filters (Cat. No. SLHV033RS, Millipore, USA) 
Glycine (Cat. No. 50046, Sigma-Aldrich, USA) 
25% Glutaraldehyde (Cat. No. G5882, Sigma-Aldrich, USA) 
CHAPS (Cat. No. C3023, Sigma-Aldrich, USA) 
 








20X saline sodium citrate buffer (SSC): 
NaCl   175.3g 
Sodium Citrate 88.2g 
Distilled water was added and pH was adjusted to 7.0 before adjusting final volume to 1 
liter. Solution was DEPC-treated and autoclaved. 
 
0.1M phosphate buffered saline with 0.1% Tween-20 (PBT): 
0.1M DEPC-treated PBS  999ml 
Tween-20    1ml 
 
Hybridization buffer: 
Formamide    25ml 
20x SSC    12.5ml 
Yeast tRNA     15mg 
Heparin    5mg 
50X Denhardt’s solution  1ml 
10% Tween 20   0.5ml 
0.1% CHAPS    0.5ml 
 




0.5M EDTA    0.5ml 
RNase-free distilled water was added up to 50ml and solution was filtered through a 
0.45µm syringe filter. 
 
Antibody Buffer: 
Heat-inactivated goat serum  1ml 
Roche Blocking Reagent  100mg 
PBT     9ml 
Blocking reagent in solution was dissolved at 70°C and filtered through a 0.45µm syringe 
filter before use. 
 
MAB Buffer: 
0.5M Maleic acid   2.4ml 
1M NaCl    1.8ml 
RNase-free distilled water  7.8ml 
pH was adjusted to 7.5 and solution was filtered through a 0.45µm syringe filter before 
use. 
 
Alkaline phosphatase (AP) buffer: 
1M Tris, pH9.5   1ml  
1M MgCl2    0.5ml 
5M NaCl    0.2ml 
 




Tween 20    10µl 
125mM levamisole   0.4ml 
RNase-free distilled water was added up to 10ml and solution was filtered through a 
0.45µm syringe filter before use. 
 
Whole-mount in situ hybridization was carried out according to the protocol published 
previously (Belo et al., 1997) with modifications. 
2.10.7.2 Procedure 
Day 1: Embryos from storage were hydrated through a descending series of methanol in 
PBT. Embryos were washed thrice in PBT and bleached with 6% hydrogen peroxide in 
PBT for 1 hour at room temperature before digesting with 10µg/ml of proteinase K in 
PBT for 30 minutes. Digestion was stopped by washing with 2mg/ml of glycine in PBT. 
Embryos were re-fixed in 4% PF with 0.2% glutaraldehyde for 15 minutes and washed 
thrice with PBT. Equilibration of embryos was performed at room temperature with 1ml 
of 50% PBT/ 50% hybridization buffer followed by 1ml of hybridization buffer for 5 
minutes each. Each embryo was pre-hybridized by removing the 1ml hybridization buffer 
and adding 900µl of hybridization buffer for 3 hours at 65°C. Prior to using, specific 
probes (1µg) were denatured at 95°C for 5 minutes. Denatured probe was then added to 
the embryos at a final concentration of 1µg/ml and hybridized overnight at 70°C.  
Day 2: The next day, the hybridization buffer with probes were removed and replaced 
with 800µl of hybridization buffer for 5 minutes at 70°C. Thereafter, 400µl of 2X SSC 
 




buffer (pH 4.5) was added and embryos were incubated at 70°C for 5 minutes. This 
addition and incubation were repeated twice with a final volume of 2ml. Mixture was 
removed and embryos were washed with 2X SSC (pH 7) with 0.1% CHAPS twice for 30 
minutes. Subsequent washings of embryos were done with MAB buffer for two times at 
70°C for 30 minutes each before washing twice with PBS at room temperature for 10 
minutes each. Each embryo was equilibrated with 1ml of antibody buffer at 4°C with 
rocking for at least 2 hours. Meanwhile, anti-dig alkaline phosphatase antibody was pre-
blocked in antibody buffer (1:1000 from a stock of 150 Units /200µl) at 4°C with rocking. 
Antibody buffer incubated with embryos were replaced with 1.5ml of pre-blocked 
antibody in antibody buffer and rocked at 4°C overnight.  
Day 3: Embryos were washed six times with 0.1%BSA in PBT for 1 hour each at room 
temperature with rocking. For the final wash, embryos were left in the solution and 
rocked overnight at 4°C to remove unspecific binding of antibodies.  
Day 4: Embryos were washed twice in PBT for 45 minutes each at room temperature. For 
color reaction, embryos were equilibrated twice in AP buffer for 10 minutes each. 
Following the last wash, the AP buffer was replaced with 1ml of AP buffer containing 
4.5µl NBT and 3.5µl BCIP for 4-36 hours depending on the abundance of the mRNA. 
The color reaction was stopped by washing the embryos thrice with PBS for 10 minutes 
each and fixing in 4% PF overnight. Whole mount pictures were taken with a 
stereomicroscope (Nikon SMZ1500; Nikon, Japan) fitted with a camera before 
 




cryosectioning transversely through the caudal neural tube. Sections were mounted with 
80% glycerol and visualized with a light microscope (Olympus BX51, Japan).  
 
2.11 Isolation of total RNA and real time reverse transcription-polymerase chain 
reaction (RT-qPCR) 
RT-PCR which couples reverse transcription and PCR is a popular method that quantifies 
the level of mRNA expression (Murphy et al., 1990). This technique developed into a 
powerful method that allows the real time quantification of RNA through the detection of 
PCR product during the exponential phase of the reaction. Real time RT-PCR (RT-
qPCR) is first made possible by the discovery of dual-labeled fluorogenic oligonucleotide 
probes which emit a fluorescent signal upon cleavage based on the principle of 
fluorescence resonance energy transfer (Cardullo et al., 1988). Since then, other 
technologies have been developed to directly measure PCR product accumulation by 
fluorescent emission. Examples include minor groove binder probes, hybridization 
probes, light-up probes, Hy-Beacon probes (Giulietti et al., 2001) and the use of a double-
stranded DNA minor groove binding dyes such as SYBR Green I (Morrison et al., 1998) 
which is a cheaper alternative than probes.  
2.11.1 Principle 
 
The use of SYBR Green I in RT-qPCR involves the binding of the fluorescent dye 
to double-stranded DNA. This fluorescent dye emits little fluorescence when it comes 
 




unbound during the denaturation phase of the PCR reaction. During the extension phase, 
newly synthesized double-stranded DNA results in the incorporation of more dye, thus 
resulting in an increase in the fluorescent signal. After several cycles of PCR reaction, the 
point at which the fluorescent signal is first recorded statistically significant above 
background signal is called the threshold cycle (Ct) (Gibson et al., 1996).  The melting 
curve of the PCR product should also be analyzed in every experiment as it provides 
important information that distinguishes primer dimers and other small amplification 
artifacts from amplified PCR products (Ririe et al., 1997).    
 
 There are two common methods of analyzing data from RT-qPCR: absolute 
quantification and quantitative quantification. In the former, it determines the input copy 
number of the transcript of interest based on the generation of a standard curve. While in 
the latter, the change in level of expression of a particular target gene can be determined 
in reference to controls that are untreated or samples at time zero in a time-course study. 
Analysis of relative gene expression data using the 2-ΔΔCt method that was described by 
Livak and coworkers is a convenient and useful way as it presents data as a fold change 
of the target gene expression normalized to an endogenous reference gene (Livak and 
Schmittgen, 2001). However, care has to be taken to ensure amplification efficiencies of 
the target and reference are approximately equal.  
 
Although RT-qPCR allows high throughput and accurate quantification, there are 
several factors that can affect the reliability of the assay such as the selection of a reliable 
 




housekeeping gene for normalization, template quality and quantity (Bustin and Nolan, 
2004) and the inherent variability of the reverse transcription reaction (Stahlberg et al., 
2004a; Stahlberg et al., 2004b). Therefore, it is essential to quality-assess components of 
the assay to minimize variability and ensure reproducibility.  
 
2.11.2 Extraction of total RNA 
RNeasy mini kit (Cat. No. 74104, Qiagen, Germany) 
2.11.2.1 Materials 
RNAlater RNA stabilization reagent (Cat. No. 74126, Qiagen, Germany) 
 
Total RNA was isolated from the caudal neural tubes of E11.5 embryos of diabetic and 
non-diabetic mice according to the manufacturer’s instructions. Freshly harvested 
embryos were immediately stabilized in RNAlater RNA stabilization reagent and caudal 
neural tubes were dissected under a stereomicroscope (Leica MZ6, Leica Microsystems, 
Germany). Caudal neural tube tissues were disrupted and homogenized in 600µl of 
Buffer RLT that contains 1% β-mercaptoethanol with a rotor-stator homogenizer until the 
sample was uniformly homogeneous. The tissue lysate was centrifuged to pellet small 
amounts of insoluble materials and the supernatant was transferred to a new 
microcentrifuge tube to be used in the subsequent steps. 600µl of 70% ethanol was added 
to the cleared lysate by pipetting and the sample was applied to an RNeasy mini column, 
2.11.2.2 Procedure 
 




centrifuged at 9000g and the flow-through was discarded. RNA bound to the silica-gel 
membrane was washed once with RW1 buffer followed by washing twice with RPE 
buffer. RNA was eluted from the column with 25µl of RNase-free water and the final 
concentration was determined spectrophotometrically at 260 and 280nm using a 
spectrophotometer (Eppendorf, Germany). 
 
2.11.3 Synthesis of first-strand cDNA 




The synthesis of first-strand cDNA from total RNA was carried out according to 
manufacturer’s instructions. Total RNA (2µg) from caudal neural tubes of embryos was 
added with 1µl of dNTP mix (10mM), 1µl of Oligo(dT) primer (0.5µg/µl) and DEPC-
treated water adjusted to 10µl in total volume. The RNA/primer mixture was incubated at 
65°C for 5 minutes before placing on ice for 1 minute. Thereafter, 2µl of 10X RT buffer, 
4µl of MgCl2 (25mM), 2µl of DTT (0.1M) and 1µl of RNaseOUT recombinant RNase 
inhibitor were added to the mixture and incubated at 42°C for 2 minutes before adding 
1µl of SuperScript reverse transcriptase. Reaction mixture was incubated at 42°C for 50 
2.11.3.2 Procedure 
 




minutes before terminating the reactions at 70°C for 15 minutes. The tube was chilled on 
ice and 1µl of RNase H was added and incubated at 37°C for 20 minutes to remove RNA. 
The synthesized cDNA was stored at -20°C.    
 
2.11.4 Real time RT-qPCR 
LightCycler FastStart DNA Master SYBR Green I (Cat. No. 12158817001, Roche 
Applied Sciences, Germany) 
2.11.4.1 Materials 
 
1µl of the synthesized cDNA products was amplified in a 20µl reaction mixture 
containing 4µl of LightCycler FastStart DNA Master SYBR Green I master mix, 
0.5µmol/l of each primer and 3mmol/l MgCl2 in a LightCycler instrument (Roche 
Applied Sciences, Germany). The PCR parameters were programmed according to the 
experimental protocol recommended by the manufacturer and Table 2 presents the 
primers that were used in the present study. The expression levels of mRNA transcripts 
were analyzed by the 2-∆∆Ct method after normalization to the housekeeping gene β-actin 
(Livak and Schmittgen, 2001). PCR products from the run were analyzed with 
electrophoresis using 1% agarose gel with ethidium bromide to ensure specificity in 
2.11.4.2 Procedure 
 




amplification of targeted genes. Visualization of bands in gels were imaged with an 
ultraviolet trans-illuminator and photographed using GeneGenius (Syngene, UK). 
 
2.12 Statistical analysis 
Statistical analysis was performed by the Student’s t-test using GraphPad Prism v5 for 
Windows (GraphPad Software, San Diego, CA) and expressed as mean ± S.E.M. 
Statistical significance was defined as  p-value of <0.05. 
 
 
Table 2. Primers and thermal profile for real time RT-qPCR. 
 
 










β-actin NM_007393.2 5’-aaccctaaggccaaccgtgaaaag-3’ 5’-gcaggatggcgtgagggagag-3’ 199 60/10 72/10 
Shh NM_009170.2 5’-ccaattacaaccccgacatc-3’ 5’-ccacggagttctctgctttc-3’ 342 60/10 72/14 
Ngn1 NM_010896.2 5’-gacactgagtcctggggttc-3’ 5’-gtcgtgtggagcaggtcttt-3’ 164 60/10 72/10 
Ngn2 NM_009718.2 5’-gatgccaagctcacgaagat-3’ 5’-acgtggagttggaggatgac-3’ 238 60/10 72/10 
Isl1 NM_021459.3 5’-cggccgcacgtccacaag-3’ 5’-tcatgatgctgcgtttcttgtcct-3’ 217 60/10 72/10 
Wnt1 NM_021279.3 5’-agccctagctgccaacagta-3’ 5’-ggaattgccatttgcactct-3’ 221 60/10 72/10 
Pax2 NM_011037.2 5’-gtgagaagaggaaacgcgaggaag-3’ 5’-gctgctgctgggtgaaggtgtc-3’ 189 60/10 72/10 
Atoh1 NM_007500.3 5’-gcttcctctgggggttactc-3’ 5’-ctgtgggatctgggagatgt-3’ 170 60/10 72/10 
Ascl1 NM_008553.4 5’-gttggtcaacctgggttttg-3’ 5’-gaacccgccatagagttcaa-3’ 225 60/10 72/10 
 





























3.1 Maternal diabetes induces neural tube closure defects in embryos  
As reported previously, about 12% of mouse embryos (E11.5) derived from 10 diabetic 
mice exhibited grossly malformed neural tubes, including cranial and caudal neural tube 
defects (Liao et al., 2004). In the present study, the present author has further 
characterized the development of neural cell types in caudal neural tubes of E11.5 
embryos from diabetic mice. In general, the normal architecture of caudal neural tubes 
and surrounding tissue in embryos of diabetic mice appeared to be perturbed extensively 
(Fig 1A-D). Moreover, the process of neurulation appeared to be impaired, resulting in 
incomplete closure of the neural plate in these affectd embryos. In a majority of the 
abnormal embryos, the caudal neural tube closure defect was apparent along the rostral-
caudal length of the axis throughout the thoracic and lumbar region from the level of 
optic vesicle anteriorly to posterior caudal neural pore of the neural tube (Fig 1B). 
Transverse sections stained with H&E showed that the neural plate failed to elevate and 
fuse at the dorsal midline in embryos of diabetic mice (Fig. 1D). Moreover, presumptive 
dorsal root ganglia lateral to the neural tube appear to be underdeveloped and displaced in 
comparison to that of embryos from normal mice (Fig. 1C, D). Prior to neural tube 
closure at E9, there was no discernible difference in neural plate shaping when comparing 
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3.2 Differentiation of neuronal cell types (moto- and inter-neurons) in the caudal 
neural tube of embryos from diabetic mice 
Since histological analysis clearly provided evidence of presence of neural tube closure 
defects in embryos of diabetic mice, it has been further analyzed whether the neural 
patterning along the dorsal-ventral axis of the caudal neural tube was perturbed using 
several appropriate molecular markers. The data obtained indicate that neural tube 
closure defect was associated with patterning defect along the dorsal-ventral axis of the 
caudal neural tube. 
  
Motoneurons and oligodendrocytes are sequentially generated in the ventral zone 
of the neural tube upon induction by Shh (Pringle et al., 1996; Orentas et al., 1999). Shh 
acts as a ventralizing signal and is expressed in the floor plate and the notochord. The 
whole mount in situ hybridization analysis showed that Shh expression domain was 
expanded ventrally in embryos from diabetic pregnancies, when compared with the 
controls (Fig. 2A-D). Quantitative real-time RT-PCR analysis further revealed the 
increased expression level of Shh mRNA in the neural tube of embryos of diabetic mice 
(Fig. 3G,H).   
 
Isl1 is one of the earliest markers for motoneuron differentiation and is expressed 
in all classes of motoneurons that innervate different groups of target muscles (Tsuchida 
et al., 1994; Pfaff et al., 1996) and in a distinct class of dorsal interneurons of the caudal 
neural tube (Liem, Jr. et al., 1997). Immunohistochemical analysis showed that the 
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percentage of Isl1 positive motoneurons appeared to be increased in the ventral zone of 
caudal neural tube in embryos of diabetic mice (Fig.3B, C). However, Isl1 positive dorsal 
interneurons (dl3) were hardly detectable in the dorsal caudal neural tube of these 
embryos (Fig 3B, C). In congruence with results from the immunofluorescence analysis, 
there was no significant difference in the overall mRNA expression of Isl1 in the caudal 
neural tubes of embryos from both groups, as revealed by the quantitative real-time RT-
PCR analysis (Fig. 3E,H). This could be due to the differential expression pattern of Isl1 
in dorsal and ventral domains of the caudal neural tubes in embryos of diabetic mice.  
 
Members of the PAX family of transcription factors control cell identity in the 
developing spinal cord. Among which Pax2 is expressed in multiple spinal interneurons 
including interneurons in the v0-v3 domains of the ventral horn (Burrill et al., 1997) as 
well as dl4 and dl6 neurons in the dorsal horn of the spinal cord (Helms and Johnson, 
2003). Immunofluorescence analysis revealed that the percentage of Pax2+ interneurons 
in the caudal neural tube was significantly reduced in embryos of diabetic mice as 
compared to controls (Figs. 3A, B, D).  The reduction was found to be consistent along 
the dorsal and ventral axis of the caudal neural tube. The quantitative real-time RT-PCR 
analysis showed that Pax2 mRNA expression level in the caudal neural tube of embryos 
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3.3 Cell cycle progression is altered in the caudal neural tube of embryos from 
diabetic mice 
Besides the altered development of different cell types in the caudal neural tubes of 
embryos from diabetic mice, the proliferation index also appeared to be altered. The 
present author has characterized the cell proliferation index by immunohistochemical 
detection of BrdU incorporation, in relation to Isl1- and Pax2-positive cells as well as 
cells stained with Tuj1, which is the neuron-specific cytoskeletal component and is a 
widely-used marker of postmitotic neurons. No Isl1+, Pax2+ and Tuj1+ cells were 
colocalized with BrdU positive cells (Fig. 4A-F), suggesting that Isl1, Pax2 and Tuj1 
proteins were expressed in the neurons of late stage differentiation. Along the dorsal-
ventral axis of the caudal neural tube, three distinct domains such as medial zone adjacent 
to central canal containing undifferentiated cells, intermediate zone containing 
proliferating cells and lateral marginal zone containing differentiated cells have been 
observed.  These domains appeared to be perturbed in the caudal neural tube of embryos 
from diabetic mice. The percentage of BrdU labeled cells in the dorsal and ventral zones 
of the neural tube was found to be significantly higher in embryos of diabetic mice when 
compared to that of normal mice (Fig. 5A-G), indicating that the majority of the cells was 
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3.4 Oligodendrocyte progenitors are increased in the caudal neural tube of embryos 
of diabetic mice 
Olig2 is a basic helix-loop-helix transcription factor that is specifically expressed in 
oligodendrocyte precursors and its expression is induced by Shh in the neural tube (Lu et 
al., 2000; Zhou et al., 2000). Whole mount in situ hybridization and immunofluorescence 
analyses showed that Olig2 expression domain was expanded and the number of Olig2+ 
cells was increased in the ventral zone of the caudal neural tube of embryos from diabetic 
mice as compared to the controls. (Figs. 6A-E). 
 
3.5 Development of radial glial cell lineages and migration of neurons are disrupted 
in the caudal neural tube of embryos from diabetic mice 
Doublecortin (Dcx), a microtubule-associated protein, is expressed in migrating 
neuroblasts and differentiating young neurons throughout the CNS and PNS during 
embryonic development (des, V et al., 1998; Gleeson et al., 1998; Couillard-Despres et 
al., 2001). The domain containing Dcx positive cells was found to be markedly attenuated 
in the ventral zone of the caudal neural tube of embryos from diabetic mice when 
compared to that of embryos from control mice (Fig. 7A-D).  
 
During early development, migration of cells in the neural tube occurs along the 
radial glial cells, which serve as neuronal progenitors, neuronal migration guides and 
astrocyte progenitors (Rakic, 1972; Hunter and Hatten, 1995; Hatten, 1999; Noctor et al., 
2001; Parnavelas and Nadarajah, 2001; Malatesta et al., 2003). There are three subsets of 
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radial glial cells that are identifiable by RC1/2 (Misson et al., 1988), Glast (Shibata et al., 
1997) and Blbp (Feng et al., 1994; Kurtz et al., 1994) antibodies. In the control neural 
tube, Blbp was expressed in cells in the ventromedial zone of the caudal neural tube. 
Immunofluorescence analysis revealed that the number of Blbp positive cells appeared to 
be decreased in the caudal neural tube of embryos from diabetic pregnancies (Figs. 7D). 
Glast was localized in the cells of the floor plate and the ventromedial zone of the caudal 
neural tube with processes that were radially-oriented towards the pial surface (Fig. 7E). 
In the caudal neural tube of embryos from diabetic mice, the number of Glast+ cells 
appeared to be markedly reduced (Fig. 7F). In addition, processes that extended towards 
the pial surface from the Blbp and Glast positive cells in the ventromedial zone were 
found to be disrupted or absent when compared to that of controls (Fig. 7C-F).  
 
3.6 Altered expression of developmental control genes in the caudal neural tube of 
embryos from diabetic mice 
Expression patterns of several genes involved in the development of variety of neuronal 
cell types including subsets of dorsal interneurons in the caudal neural tube have been 
analyzed. Wnt1 is expressed in the dorsal neural tube from the forebrain to the spinal cord 
levels at the time of neural crest generation (Wilkinson et al., 1987; Parr et al., 1993). In 
situ hybridization analysis showed that the Wnt1 expression was restricted to the roof 
plate and the adjacent area of the caudal neural tube in control embryos. Neural 
progenitors that are adjacent to the roof plate expressed Atoh1, the bHLH transcription 
factor (Helms and Johnson, 1998). These Atoh1-expressing neural progenitors give rise 
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to dl1 class of dorsal interneurons (Bermingham et al., 2001). There seems to be no 
apparent differences in expression pattern of Wnt1 (Fig. 8A-H) and Atoh1 (Fig. 9A-H) in 
both the normal and open neural tubes in the present study.  
 
Ngn1 (another bHLH transcription factor) expression is located ventral to the 
Atoh1 expression domain in the caudal neural tube (Lee et al., 1998a; Gowan et al., 2001). 
Coordination with its related factor, Ngn2 is required for normal formation of the DRG 
and the dorsal interneuron population dl2 (Ma et al., 1999; Gowan et al., 2001; Nieto et 
al., 2001). The in situ hybridization showed Ngn1 was expressed in the domain 
containing dl2 and dl5 interneurons (Fig. 10A-H). Expression domain of Ngn1 in the 
open neural tube appeared to be expanded dorsally (Fig. 10H). On the other hand, Ngn2 
was found to be expressed in both ventral and dorsal domains of caudal neural tubes. In 
the dorsal domain, expression of Ngn2 was restricted in the region where dl2-5 neurons 
were formed. In the open neural tube of embryos from diabetic mice, Ngn2 expression 
domain appeared to be expanded ventrally (Fig. 11A-H). Ascl1 was shown to be 
necessary for the development of most dl3 and all dl5 neurons with low level of Ascl1 
giving rise to dl4 neurons (Helms et al., 2005). Ascl1 was expressed in progenitor 
domains containing dp3-5 cells in the control neural tube while expression was observed 
to be intensified and expanded in dp3-5 domain of the open neural tube (Fig. 12A-H).  
 
Expression levels of Wnt1, Atoh1, Ngn1, Ngn2 and Ascl1 were quantified by real 
time RT-qPCR. Real time RT-qPCR analysis confirmed the increased expression levels 
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of Ngn1, Ngn2 and Ascl1 in the neural tubes of embryos from diabetic mice. However, 
there was no change in the expression levels of Wnt1 and Atoh1 in the neural tubes of 
embryos from diabetic mice compared to that of embryos from controls (Fig. 13A-F).  
 
Part II 
3.7 Maternal diabetes induced defects in the developing DRG 
Transverse sections of caudal neural tubes with E11.5 embryos stained with H&E 
revealed architecture disruption of the surrounding tissues (Fig. 1C, D). The DRG 
appeared to be under-developed and displaced in comparison to that of a normal embryo.  
 
3.8 Cell proliferation and specification of mature neurons were impaired in the 
DRG of embryos from diabetic mice 
Tuj1, a neuron-specific cytoskeletal component, is a widely-used marker to characterize 
postmitotic neurons. Immunofluorescence with anti-Tuj1 revealed that the percentage of 
Tuj1+ neurons in the DRG was significantly reduced in embryos of diabetic mice as 
compared to controls (22.06±3.52% versus 38.50±5.01%, p<0.05; Fig. 14A-G).  
 
It is hypothesized that a decrease in the proliferation index or an increase in the 
apoptotic index may lead to the impaired development of the DRG. The percentage of 
BrdU labeled cells in the DRG was observed to be significantly lower in embryos from 
diabetic mice when compared to embryos from normal mice (6.87±1.61% versus 
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16.67±1.68%, p<0.01; Fig. 15A-G). Moreover, apoptotic cells were found to be hardly 
detectable in the DRG of both groups of embryos (Fig. 16A-F).  
 
3.9 Development of the sympathetic chains in embryos of diabetic mice are affected 
The sympathetic chain is a fundamental part of the sympathetic division of the autonomic 
nervous system and it runs from the base of the skull to the coccyx. The sympathetic 
chains (one right and one left in the body) permit nerve fibers to travel in the spinal 
nerves. Tyrosine hydroxylase (TH), a marker of peripheral sympathetic ganglion neurons, 
was used to analyze the development of the sympathetic chains. Fewer TH positive cells 
were detected in embryos of diabetic mice in comparison to that of embryos from control 
mice (Fig. 17A, B). 
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Neural tube defects (NTDs) which most commonly manifest as exencephaly and spina 
bifida have been widely reported in studies of human diabetic embryopathy (Kucera, 
1971; Becerra et al., 1990). However, very little information is known about the cellular 
changes and the etiology of NTDs although complex multifactorial genetic and 
environmental components appear to be involved. In the present study, about 12% of 
embryos derived from diabetic mice exhibit neural tube closure defects resulting from 
failure of fusion of the neural plate at the dorsal midline during neurulation which occurs 
at E8.5-9.5.  Moreover, the spinal neural tube closure defects appear to be associated with 
cellular patterning defects as was observed earlier in the forebrain (Liao et al., 2004). 
 The complete neurulation and neural patterning require precisely regulated 
interactions among several signaling molecules and transcription factors that control the 
cell proliferation, differentiation as well as the position of different cell types in the 
developing neural tube. During pregnancy, environmental factors or teratogenicity 
including maternal diabetes seem to alter those molecules contributing eventually to 
neural tube anomalies. It has been previously shown that exposure to high glucose alters 
the cell-cycle progression in NSCs, microvessel endothelial cells and mesangial cells 
(Wolf et al., 2001; Abraham et al., 2003; Fu et al., 2006). In the present study, the 
number of proliferating cells was found to be increased in the dorsal and ventral domains 
of the spinal neural tube of embryos from diabetic mice, indicating the altered cell cycle 
machinery and possible delay in the differentiation process. However the process of 
differentiation appeared to vary between the cell types as there were more motoneurons 
as well as oligodendrocytes and less interneurons in the caudal neural tube of embryos 
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from diabetic mice.  This differential response between the cell types could be due to the 
influence of distinct local factors responding to glucotoxicity caused by maternal diabetes.  
The patterning of the central nervous system depends on the subdivision of the 
neural epithelium into distinct regional domains and the generation of a diverse array of 
neuronal cell types within each domain. The early regionalization of the neural 
epithelium appears to be regulated by inductive factors secreted by signaling centers in 
and adjacent to the neural tube (Lumsden and Krumlauf, 1996; Tanabe and Jessell, 1996). 
Genetic studies and in vitro assays have provided evidence that signaling factors of the 
Wnt, FGF, and Hedgehog families have prominent roles in the specification of these 
regional domains (McMahon and Bradley, 1990; Thomas and Capecchi, 1990; Chiang et 
al., 1996; Crossley et al., 1996; Ikeya et al., 1997; Ye et al., 1998). Although the present 
study does not reveal the molecular mechanisms that contribute to the neural tube 
anomalies, it provides a clue for changes in molecular cues that guide the development of 
different functional regions of the spinal cord after the period when the neural tube 
closure occurs. 
In the ventral neural tube, distinct neuronal cell types are organized in a grid-like 
manner by inductive signals from signaling centers, the notochord and floor plate 
(Placzek, 1995). Shh secreted initially from the notochord and later from floor plate cells, 
has been implicated in the induction of ventral neuronal cell types including the Isl-1+ 
motoneurons in the spinal cord  (Marti et al., 1995a; Chiang et al., 1996). In the present 
study, upregulation of Shh in the neural tube of embryos from diabetic mice appeared to 
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have induced the generation of ventral Isl1+ motoneurons in the caudal neural tube. 
However, loss of Isl1+ dl3 interneurons in the dorsal neural tube indicates the 
involvement of dorsal signals which may be regulated negatively by maternal diabetes. 
On the other hand, the decreased Pax2 mRNA expression and number of Pax2+ 
interneurons that are found in v0-v3 domains of the ventral neural tube and dl4 and dl6 
domains of the dorsal neural tube in embryos of diabetic mice indicate that these embryos 
exhibit defects in the specification of neuronal cell types along the dorsoventral axis of 
the developing spinal cord. It is possible that upregulation of Shh in embryos of diabetic 
mice promotes motoneuron differentiation in the ventral neural tube at the expense of 
Pax2-expressing interneurons. Moreover, involvement of dorsal signal in the loss of 
Pax2+ dl4 and dl5 interneurons in embryos of diabetic mice cannot be excluded as dorsal 
midline cells have been shown to provide signals that are required for the generation of 
distinct classes of dorsal interneurons (Liem, Jr. et al., 1997).  
 
Oligodendrocytes are the myelinating glial cells of the CNS and their precursors 
are identifiable in the same ventral region of the neuroepithelium of the developing spinal 
cord where motoneurons are generated (Sun et al., 1998). The generation of 
oligodendrocyte precursors is regulated by ventralizing signaling of Shh which acts by 
inducing the expression of Olig1/2 genes, the differentiation factors of oligodendrocytes  
(Lu et al., 2000; Zhou et al., 2000; Alberta et al., 2001). In the developing spinal cord, 
Olig2 is expressed in the pMN progenitor domain, and is required for the sequential 
generation of motoneurons and oligodendrocytes from the pMN domain (Takebayashi et 
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al., 2000; Mizuguchi et al., 2001; Novitch et al., 2001; Lu et al., 2002; Zhou and 
Anderson, 2002). It has been shown that Olig2 regulates the expression of Ngn2 which 
promotes the expression of pan-neuronal markers in the pMN domain of the spinal cord 
(Novitch et al., 2001) and both Olig2 and Ngn2 appear to function downstream of Shh to 
direct the generation of motoneurons (Mizuguchi et al., 2001). In the present study, the 
increased expression of Shh was associated with expanded Olig2 and Ngn2 expressing 
domains in the ventral spinal cord, indicating that upregulation of Shh is the key factor 
that expands the boundaries of transcription factor gene expression in the ventricular zone 
of the spinal cord. These changes could alter the landscape of the neuronal and glial 
progenitors domains established at earlier stages, resulting in a series of changes in 
specification of various cell types leading to altered patterning of the developing ventral 
spinal cord in embryos of diabetic mice.  
 
 Olig1/2 genes have also been shown to act on cell fate choice between 
oligodendrocytes and astrocytes (Zhou and Anderson, 2002). In Olig1/2 mutants, many 
Olig2 expressing oligodendrocyte precursors are transformed into astrocytes (Zhou and 
Anderson, 2002). The astroctyes are differentiated from radial glial cells which express 
Glast/Blbp in the normal developing spinal cord (Barry and McDermott, 2005). It is 
possible that the impaired development of Glast/Blbp positive cells in the ventral spinal 
cord of embryos from diabetic mice could be due to increased number of Olig2+ cells in 
the pMN domain. Moreover, the radial glial cells which extend their processes from the 
ventricular zone to the pial surface in the caudal neural tube, serve as a guidance scaffold 
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for migrating neurons and appear to be necessary for cell patterning and regionalization 
of the developing nervous system (Campbell and Gotz, 2002; Kriegstein and Gotz, 2003). 
The decreased number of Glast/Blbp positive radial glial cells showing short processes in 
the neural tube of embryos from diabetic mice indicates the impaired neuronal migration 
which could result in topographic positional disarray leading to defective neural tube 
patterning.  
 
During neurodevelopment, the differentiated neurons migrate laterally from the 
ventricular zone and begin to exhibit their specific neuronal identities. The migration of 
immature neurons to their respective positions is a crucial step in the organization and 
development of the neural tube. There is a complex interplay between extrinsic and 
intrinsic factors that mediate the precise timing of cell-cycle exit, cell migration and 
initiation of cellular properties specific to newborn neurons. The migrating neurons 
express Dcx gene, mutation of which results in abnormal neuronal migration, epilepsy, 
and mental retardation in humans (Reiner et al., 2006). The marked reduction of Dcx 
positive cells in the developing ventral spinal neural tube of embryos from diabetic mice 
further confirms the impaired neuronal migration, indicating the potential consequences 
which may lead to mental retardation in offspring of diabetic mothers. 
 
 
The dorsal spinal cord contains a diverse array of neurons which are largely 
differentiated between E10-E14 in mouse. These neurons connect sensory input from the 
periphery to motoneurons in the spinal cord and higher centers in the brain. The 
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specification of dorsal neural cell fates requires dorsalizing signals including secreted 
proteins of Wnt families from the roof plate. Wnt1 is expressed along the dorsal midline 
from the diencephalon to the spinal cord (McMahon et al., 1992; Parr et al., 1993) during 
neurogenesis and is required for the expansion of dorsal neural progenitors (Ikeya et al., 
1997).  There are six dorsal neuronal populations (dl1-dl6) defined by expression of 
homeodomain and bHLH factors and position in the dorsoventral axis (Caspary and 
Anderson, 2003; Helms and Johnson, 2003). The generation of dl1-dl3 neurons are 
dependent on roof plate signals, whereas dl4-dl6 neurons form independently of these 
signals (Lee et al., 2000; Zhou and Anderson, 2002; Gross et al., 2002; Muller and 
Rohrer, 2002). Moreover, these neurons (dl1-dl6) have been found to be originated from 
Atoh1+, Ngn1+, Ascl1+ progenitors (Gowan et al., 2001; Helms et al., 2005). Expression 
domains of Atoh1, Ngn1 and Ascl1 within the dorsal neural tube appear sequentially 
along the dorsoventral axis from the roof plate (Lo et al., 1991; Guillemot and Joyner, 
1993; Helms and Johnson, 1998; Lee et al., 1998a; Gowan et al., 2001). Although the 
expression domains of these genes do not overlap obviously, Ngn2 (another bHLH 
factor) expression domain partially overlaps with Atoh1, Ngn1 and Ascl1 expression 
domains. Except Wnt1 and Atoh1 which are expressed in the roof plate and ventricular 
zone cells adjacent to the roof plate, expression levels and domains of the rest of the 
genes appear to be increased in the developing spinal neural tube of embryos from 
diabetic pregnancy, indicating that the generation of the correct number and types of 
neurons in the dorsal neural tube is perturbed. For example, Ascl1 promotes the 
generation of most dl3 and all dl5 neurons and antagonizes the generation of dl4 neurons 
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(Helms et al., 2005).  Upregulation of Mash-1 expression appears to be associated with 
decreased number of Pax2+ dl4 interneurons in the spinal neural tube of embryos from 
diabetic mice.  However, the decreased number of Isl1+ dl3 interneurons in these 
embryos indicates the complexity of the defect in the differentiation process.  The 
complex connections of these dorsal neuronal cell types contribute to the circuitry of the 
spinal cord. Thus, abnormal development of these cell types could impair the functions of 
the spinal cord in offspring of diabetic mothers.  
   
Sensory neurons of the DRG which are derivatives of the neural crest cells were 
also found to be impaired by maternal diabetes. The impaired development of DRG in 
embryos of diabetic mice was associated with lower proliferation index. However the 
impaired proliferation index was not associated with increased apoptosis as observed in  
DRG neurons in hyperglycemia experiments (Schmeichel et al., 2003; Vincent et al., 
2005). Studies have indicated that the hyperglycemic environment increases levels of 
cellular reactive oxygen species (ROS) (Leinninger et al., 2006). Cells produce ROS via 
the mitochondrial transport chain and the hyperglycemic cell metabolizes more glucose, 
thereby increasing the production of free radicals. Impaired proliferation in DRG neurons 
may be associated with increased ROS production. Tyrosine hydroxylase, a marker 
which marks the development of sympathetic chains was found to be significantly 
decreased, providing evidence of damage to the PNS in a hyperglycemic environment. 
Such collective damage to the DRG and sympathetic chains of the PNS together with 
 
Chapter 4: Discussion 
88 
 
occurrence of spina bifida could exacerbate the functional deficit in CNS and PNS of 
offspring of diabetic mothers.  
  
Overall, the open neural tube in embryos of diabetic mice exhibit defects in the 
precise timing of cell-cycle exit, cell migration and specification of different cell types 
including motoneurons and interneurons as well as glial cells along the dorsoventral axis 
of the developing spinal cord (Illustration 4). As these neuronal cell types in the spinal 
cord provide an intricate network that modulates the sensory and motor outputs in both 
peripheral and central nervous systems, defective development of these cell types may 
impair the circuitry of the entire nervous system in offspring of diabetic mothers. 
Although these defects are associated with altered expression of several development 
control genes, the exact mechanisms by which maternal diabetes contributes to these 
changes remain to be investigated systematically. 
 
 




Illustration 4. A flow chart summarizing the changes in various factors and expression 
of genes that possibly associated with neural tube dysmorphogenesis and impaired 
development of PNS in embryos of diabetic mice.   
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It has been shown that maternal diabetes induces a wide array of congenital 
malformations including NTDs (such as spina bifida). This risk is two to six times higher 
in the diabetic pregnancy compared to that in a normal pregnancy (Freinkel, 1988; 
Eriksson, 1995; Suhonen et al., 2000) and is associated with poor glycemic control during 
the first trimester as compared with later stages in pregnancy (Miller et al., 1981; 
Kitzmiller et al., 1991). Spina bifida is a debilitating disability that results from the 
incomplete closure of the embryonic neural tube during development. Although vast 
improvements in surgical and medical management has decreased the mortality rate of 
individuals with spina bifida, patients often do not recover completely and they continue 
to experience varying degrees of motor and sensory dysfunction.  The average worldwide 
incidence for spina bifida is estimated at around 1 case per 1000 births. In the United 
States, the average incidence is 0.7 per 1000 live births with a higher incidence in whites 
than in blacks (Lemire, 1988; Cotton, 1993). In Singapore, the incidence for NTDs 
during the period of 1993-2002 is 0.91 per 1000 live births, with spina bifida and 
anencephaly as the two major occurring NTDs (Ministry of Health, 2002).  
 
 The etiology of NTDs that arises from maternal diabetes has been the subject of 
intensive research in recent years (Evers et al., 2004; Cleves and Hobbs, 2004). Oxidative 
stress signaling, metabolic disorders and altered gene expression profiles have been 
widely implicated in diabetic embryopathy. It has been shown that ROS mediates 
oxidative stress-induced apoptosis and is associated with diabetes-induced congenital 
malformations (Zangen et al., 2002; El-Bassiouni et al., 2005; Yang et al., 2008). In 
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addition, dietary supplements of antioxidants like vitamins E and C have been reported to 
reduce the frequency of such fetal malformations, further supporting the role that 
oxidative stress plays an important role in the etiology of maternal diabetes-induced 
malformations (Siman and Eriksson, 1997a; Siman and Eriksson, 1997b; Chang et al., 
2003). Several studies also demonstrated that fetal abnormalities are associated with 
metabolic disorders such as glucocorticoid dysregulation (Fujisawa et al., 2007), 
deficiency in arachidonic acid (Goldman et al., 1985) and increase in the levels of 
superoxide dismutase (Cederberg et al., 2000). The altered expression of several 
important developmental genes involved in the neural tube development such as Pax3 
appeared to have contributed to fetal dysmorphogenesis (Fine et al., 1999; Chang et al., 
2003). Research from our laboratory has also previously shown the altered expression of 
several developmental genes involved in the cell-fate specification of embryonic neural 
stem cells and patterning of the telencephalon (Liao et al., 2004; Fu et al., 2006).  
 
 The development of the caudal neural tube is an important event during 
embryogenesis as it is the preseumptive structure of the spinal cord that functions in the 
transmission of neural information between the PNS and the brain. In the present study, 
maternal diabetes was found to impair the development of various cell types such as 
motoneurons, interneurons, oligodendrocytes, migrating neurons and radial glial cells in 
the developing spinal cord. An elevated expression of the ventralizing signal Shh in the 
floor plate of caudal neural tube in embryos from diabetic mice appeared to induce 
several changes in the ventral neural tube. Shh induces the generation of Isl1+ 
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motoneurons in the ventral neural tube and this is coupled with a loss of motoneurons in 
the dorsal neural tube, thus suggesting the involvement of dysregulated dorsal signals 
from the open neural tube. The upregulation of Shh also appears to promote the 
differentiation of motoneurons at the expense of Pax2+ interneurons in the ventral neural 
tube as a decreased expression of Pax2+ interneurons was observed. In addition, the 
upregulation of Ascl1, a proneural gene that antagonizes the generation of dl4 neurons 
(Helms et al., 2005), seems to cause a decrease in the number Pax2+ dl4 interneurons in 
the neural tubes of embryos from diabetic mice. The expression domains of Olig2 and 
Ngn2 were observed to have expanded in the ventral neural tube of embryos from 
diabetic mice as both of these bHLH factors function downstream of Shh to generate 
motoneurons and oligodendrocytes sequentially in the pMN domain (Mizuguchi et al., 
2001).  
 
 Radial glial cell processes that express Glast and Blbp serve as scaffolding tracks 
for the migration of neurons from the ventricular zone to the pial surface during the 
patterning of the neural tube (Campbell and Gotz, 2002; Kriegstein and Gotz, 2003). In 
the ventral neural tube of embryos from diabetic mice, the reduction of these processes 
and the number of migrating neurons which express Dcx provide evidences and suggest 
that impaired neuronal migration resulted in the defective DV patterning of the open 
neural tube that was observed.  
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 In addition to the impaired topographic positions of various neurons in the neural 
tube, development of sensory neurons in the developing DRG and sympathetic neurons in 
the sympathetic ganglia of embryos from diabetic mice also appeared to be affected. 
Although spina bifida can be surgically repaired, this does not restore normalcy to the 
affected part and patients will continue to have some sensory and motor dysfunction. This 
could be due to the impaired DV patterning of the neural tube by an alteration in the 
expression of several important developmental genes and a loss of motoneurons in the 
dorsal aspect and sensory neurons in the DRG. The findings in the present study clearly 
demonstrated the involvement of altered developmental gene expressions as one of the 
factors for the basis of defective neural tube patterning in spina bifida. Although the exact 
mechanisms by which maternal diabetes induces spina bifida is unclear, the present study 
is of clinical importance as it provides new avenues of research directions to develop new 
and safer therapeutic options to reduce or eliminate embryonic malformations induced by 
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Fig.1. E11.5 mouse embryos obtained from normal (A) and diabetic (B) mice. The 
embryo from the diabetic mouse exhibits incomplete closure of the caudal neural tube 
along the rostral-caudal length of the axis (B,D arrows). Transverse sections (C,D) of the 
caudal neural tube at the level of top of the upper limbs stained with Hematoxylin and 
Eosin show failure of fusion of neural plate at the dorsal midline coupled with 
underdeveloped dorsal root ganglia in the embryo from the diabetic mouse. Scale bar (A-























Fig.2. Whole mount in situ hybridization for Shh mRNA expression in embryos of 
normal (A) and diabetic (C) mice. Expression domain of Shh is greatly increased (arrows) 
in the embryo from diabetic mouse along the entire rostral-caudal length of the axis. 
Transverse sections (plane shown in A, C) through caudal neural tube of whole mount in 
situ hybridization embryos from normal (B) and diabetic (D) mice showing expression 























Fig.3 (A-D). Immunohistochemical analysis on transverse sections of E11.5 embryos 
from control (A) and diabetic mice (B) show expression of Isl1 (green), a marker for 
motoneurons and Pax2 (red), a marker for interneurons. Sections are counterstained with 
DAPI (blue). The percentage of Isl1+ motoneurons appeared to be increased significantly 
in the ventral zone of the caudal neural tube whereas the percentage of Pax2+ 
interneurons in the caudal neural tube is significantly reduced in embryos of diabetic 
mice (A-D). Data represent mean ± S.E.M. *p<0.05; **p<0.01. Scale bar: 200µm. D, 
























Fig.3 (E-H). Isl1 (217bp), Pax2 (189bp) and Shh (342bp) mRNA products were 
amplified by PCR and specificity of the products were confirmed with the respective 
melting curve analysis (E-G). Real-time RT-qPCR analysis (H) shows that Pax2 
expression is decreased and Shh expression is increased in embryos from diabetic mice. 
However, there is no significant change in overall expression of Isl1 between the control 
























Fig.4. Transverse sections through caudal neural tube of E11.5 embryos showing double 
immunofluorescence labelling for Isl1 (green) and BrdU (red) (A,B), Pax2 (green) and 
BrdU (red) (C,D), and Tuj1 (green) and BrdU (red) (E,F). The sections are 
counterstained with DAPI (blue). Note that there are no colocalization of these neurons 
























Fig.5. Proliferation index by BrdU incorporation in the transverse sections of the caudal 
neural tube of E11.5 embryos from control and diabetic mice (A-F). The percentage of 
BrdU positive cells appeared to be significantly increased in the dorsal and ventral zone 
of the caudal neural tubes of embryos from diabetic mice, suggesting that a majority of 
the cells are in the proliferation zone (G). Panels C-F are high magnification of regions 
shown (square) in panels A and B. Data represent mean ± S.E.M. *p<0.05; **p<0.01. 























Fig.6. Transverse sections of the caudal neural tube showing mRNA expression by in 
situ hybridization (A,B) and protein expression by immunofluorescence (C,D) of Olig2. 
Expression domain of Olig2 (arrows) appears to have increased in the caudal neural tube 
of embryos from diabetic mice. Consistently, the number of Olig2 positive cells (arrows) 
is also increased in the ventral zone of the caudal neural tube in embryos of diabetic mice, 
compared to that of embryos from control mice (C-E). Data represent mean ± S.E.M. 






















Fig.7. Transverse sections through caudal neural tube of E11.5 embryos showing double 
immunofluorescence labelling for Dcx (green) and Blbp (red) (A-D) and single 
immunofluorescence staining for Glast (green) (E, F). The sections are counterstained 
with DAPI (blue). Dcx expression has been observed in the cells of ventromedial caudal 
neural tubes in embryos of control mice (A,C) while the Dcx+ cells are markedly reduced 
in embryos of diabetic mice (B,D). Processes that extend towards the pial surface (arrows) 
from Blbp- and Glast- positive cells are found to be disrupted in caudal neural tubes of 
























Fig.8. Whole mount in situ hybridization for Wnt1 mRNA expression in embryos of 
normal (A-C) and diabetic (D-F) mice. Transverse sections (plane shown in A,D) through 
caudal neural tube of whole mount in situ hybridization embryos from normal (G) and 
diabetic (H) mice. Expression of Wnt1 appears to be unaltered in embryos from control 

























Fig.9. Whole mount in situ hybridization for Atoh1 mRNA expression in embryos of 
normal (A-C) and diabetic (D-F) mice. Transverse sections (plane shown in A,D) through 
caudal neural tube of whole mount in situ hybridization embryos from normal (G) and 
diabetic (H) mice. Expression of Atoh1 appears to be unaltered in embryos from control 

























Fig.10. Whole mount in situ hybridization for Ngn1 mRNA expression in embryos of 
normal (A-C) and diabetic (D-F) mice. Transverse sections (plane shown in A,D) through 
caudal neural tube of whole mount in situ hybridization embryos from normal (G) and 
diabetic (H) mice. Expression domain of Ngn1 in the neural tube of embryos from 

























Fig.11. Whole mount in situ hybridization for Ngn2 mRNA expression in embryos of 
normal (A-C,G) and diabetic (D-F,H) mice. Transverse sections (plane shown in A,D) 
through caudal neural tube of whole mount in situ hybridization embryos from normal (G) 
and diabetic (H) mice. Expression domain of Ngn2 in the neural tube of embryos from 

























Fig.12. Whole mount in situ hybridization for Ascl1 mRNA expression in embryos of 
normal (A-C) and diabetic (D-F) mice. Transverse sections (plane shown in A,D) through 
caudal neural tube of whole mount in situ hybridization embryos from normal (G) and 
diabetic (H) mice. Ascl1 expression domain has been found to have expanded in the 


























Fig.13(A-E). Wnt1 (221bp), Atoh1 (170bp), Ngn1 (164bp), Ngn2 (238bp) and Ascl1 
(225bp) mRNA products were amplified by PCR and specificity of the products were 



























Fig.13(F). Real time RT-qPCR analysis of Wnt1, Atoh1, Ngn1, Ngn2 and Ascl1. 
Expression levels of Ngn1, Ngn2 and Ascl1 show an increase in the neural tubes of 
embryos from diabetic mice in comparison to the controls. Data represent mean ± S.E.M. 


















Fig.14(A-F). Immunohistochemical analysis on transverse sections of E11.5 embryos 
from control (A,B,D,E) and diabetic mice (C,F) show expression of Tuj1 (green), a 
marker for post-mitotic neurons. Sections are counterstained with DAPI (blue). 
Expression of Tuj1 appears to be reduced significantly in DRG of embryos from diabetic 
mice as compared to that of controls. Panels D-F are high magnification of DRG in 


























Fig. 14(G). The percentage of Tuj1+ post-mitotic neurons in the DRG is reduced 


























Fig.15. Proliferation index by BrdU incorporation in the DRG of E11.5 embryos from 
control and diabetic mice (A-F). Sections are counterstained with DAPI (blue). The 
percentage of BrdU positive cells appears to be significantly decreased in the DRG of 
embryos from diabetic mice, suggesting that the lack of proliferation contributed to 
under-developed DRG (G). Panels C-F are high magnification of regions shown (dashed 
lines) in panels A and B. Data represent mean ± S.E.M. **p<0.01. Scale bar: (A,B) 
























Fig.16. Apototic index by TUNEL assay in the DRG of E11.5 embryos from control and 
diabetic mice (A-F). Sections are counterstained with DAPI (blue). Apoptotic cells were 
hardly detectable in the two groups. Panels C-F are high magnification of regions shown 

























Fig.17. Immunohistochemical analysis of transverse sections of E11.5 embryos from 
control (A) and diabetic mice (B) shows expression of tyrosine hydroxylase (green), a 
marker for sympathetic ganglia. Sections are counterstained with DAPI (blue). Number 
of cells expressing tyrosine hydroxylase (arrows) appears to be decreased significantly in 
embryos of diabetic mice as compared to the controls, suggesting under-development of 
the sympathetic ganglia. Scale bar: 50µm. 
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